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Introduction
In former times, mathematics was considered as an intellectual, even spiritual
discipline, that had little to do with the real word. Nowadays, mathemat-
ics finds application in the physical, biological, and social sciences, and in
some of the humanities as well. There appears to be no branch of orga-
nized knowledge that cannot benefit -at least to some extent- from the use of
mathematical reasoning. Cancer research belongs to one of the various field
of biology that may benefit from mathematical treatment.
Macroscopic and microscopic tumors are, quite soon after their first phases
of growth, composed by a large to huge number of cells. Thus, in absence
of external perturbations, their growth and, in some cases ,as we shall see in
this thesis,only up to some extent, equilibrium may be described by differen-
tial equations. These can also be used to model perturbations due to human
intervention to cure the disease. However, tumor strongly interact on its
macroenvironment and as a result a totally deterministic description may be
sometime highly inappropriate. In this case the interplay with the statistical
fluctuation due to external disturbances (”extrinsic noises”) can be take into
account by using Ito-Langevin stochastic differential equations (SDE) fields.
This is specially true when modelling highly immunogenic tumors interplay-
ing with the immune system, since the complexity of this interaction results
in multistability. Thus, the noise may induce noise-induced state transitions
(NITs). We point of that a NIT in the tumor size has deep implication on
the life of a patient, since a transition from a small equilibrium state of the
tumor size to a macroscopic equilibrium in most cases means, unfortunately,
a transition from life to death. Note also that, from the point of view of the
tumor, this is a clear illustration of the emerging concept that in many cases
”noise is not a nuisance”.
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Apart oncology, SDE-based models and NITs were extensively used in all
fields of biomathematics in last 35 years, since seminal works by Horstemke,
Lefever and the late Nobel laureate Ilya Prigogine. The standard approach is
to model stochastic fluctuations of parameters by means of white or colored
Gaussian noise. Very recently, it has pointed out that in some important
cases this procedure is highly inappropriate, due to the intrinsic unbounded-
ness of Gaussian noises, which can lead to serious biological inconsistencies:
bounded noises must be used, which, however, are far less studied than gaus-
sian noises. Moreover, the onset of NITs depends on the kind of chosen noise,
which reveals a novel level of complexity in biology.
The aim of this thesis is to study the applications of bounded-noise induced
transitions in two important cases: Tumor Immune-System interplay, and
chemotherapy of tumors. In the former case, we also introduce a novel math-
ematical model of the therapy, which in a new way extends the well-known
Norton-Simon biological hypothesis and model.
The thesis is organized as follows:
The first chapter gives an introduction to cancer. I will explain causes,
symptoms,diagnosis, stages and treatments of the disease giving also a clas-
sification of tumor different types.
In the second chapter I will show some Mathematical models in cancer re-
search divided in carcinogenesis models and models of tumor growth giving
also an introduction to chemotherapy models.
In the third chapter I will explain a family of models modeling tumor-immune
system competition, and also some numerical simulations regarding the in-
terplay lymphoma-Immune System in chimeric mice.
The forth chapter gives an introduction to noise explaining the meaning of
white noise and how to introduce it in some deterministic equations leading
to stochastic differential equations.
In chapter five I introduce bounded noises, with particular regard to the cre-
ation of bounded ”Sine Wiener noise” and bounded ”Cai noise”.
In chapter six I illustrate the effect of bounded stochastic fluctuations in
some key parameters of the above mentioned model of tumor-immune sys-
tem interaction, by means of the use of Sine-Wiener and Cai noises.
In chapter seven I will study a realistic biophysical model of tumor growth in
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presence of the delivering of a constant continuous chemotherapy introducing
some stochastic bounded fluctuations that affect both carrying capacity of
the tumor and drug level in the blood and showing that they might cause
the transition from a low equilibrium to a larger value, not compatible with
the life of the host.
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Chapter 1
Understanding Cancer
In most people’s minds there is no scarier diagnosis than that of cancer.
Cancer is often thought of as an untreatable, unbearably painful disease with
no cure. Although in last 40 years treatment of some kind of tumors
has luckily had remarkable success, cancer is undoubtedly a very
serious and potentially life-threatening illness. Millions of people die
from cancer every year and worldwide trends indicate that millions more will
die from this disease in the future. For example, it is the leading cause of
death in Americans under the age of 85, and the second leading cause of
death in older Americans [Eve10]. However popular this view of cancer may
be, it is over-generalized. It is a misconception to think that all forms of
cancer are untreatable and deadly. The truth of the matter is that there are
multiple types of cancer, many of which can today be effectively treated so
as to eliminate, reduce or slow the impact of the disease on patients’ lives.
Great progress has been achieved in fields of cancer prevention and surgery
and many novel drugs are available for medical therapies. While a diagnosis
of cancer may still leave patients feeling helpless and out of control, in many
cases today there is cause for hope rather than hopelessness.
1.0.1 What is Cancer?
Human’s body is composed of many millions of tiny cells, each a self-contained
living unit. Normally, each cell coordinates with the others that compose
tissues and organs of the body. One way that this coordination occurs is
29
reflected in how cells reproduce themselves. Normal cells in the body grow
and divide for a period of time and then stop growing and dividing. There-
after, they only reproduce themselves as necessary to replace defective or
dying cells. Cancer occurs when this cellular reproduction process goes out
of control. In other words, cancer is a disease characterized by uncontrolled,
uncoordinated and undesirable cell division. Unlike normal cells, cancer cells
continue to grow and divide for their whole lives, replicating into more and
more harmful cells. The abnormal growth and division observed in cancer
cells is caused by damage in these cells’ DNA (genetic material inside cells
that determines cellular characteristics and functioning). There are a variety
of ways that cellular DNA can become damaged and defective. For exam-
ple, environmental factors (such as exposure to tobacco smoke) can initiate a
chain of events that results in cellular DNA defects that lead to cancer. Alter-
natively, defective DNA can be inherited from parents. As cancer cells divide
and replicate themselves, they often form into a clump of cancer cells known
as a tumor. Tumors cause many of the symptoms of cancer by pressuring,
crushing and destroying surrounding non-cancerous cells and tissues.
1.0.2 Tumor classification
We may classify tumors in two different ways:
• Behavioral classification:
The greatest distinction of tumor types is between Benign and Malig-
nant:
Benign Tumors: are not cancerous, thus they do not grow and
spread to the extent of cancerous tumors. They are generally
slow growing expensive masses , often with ”pushing margins”
and enclosed within a fibrous capsula.
Malignant Tumors: They are usually rapidly growing, invading
local tissue and spreading to distant sites. The process whereby
cancer cells travel from the initial tumor site to other parts of the
body is known as metastasis.
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It must be noticed that there are some benign tumors that predispose
to malignancy and some in situ carcinomas that progress so slowly that
they may never achieve malignancy. Anyway the ability to metastasize
is evidence of malignancy.
• Histogenetic classification:
The most efficient way to classify tumors is according to the tissue of
origin and the cell type involved. Problems in this kind of classification
arise because some tumor cells grow in such a way that they bear
no resemblance to any structure or cell type. Such anaplastic tumors
require more detailed investigation to discover their histogenesis 1. A
further problem is that sometimes a tumor resembles tissue which is
not normally present at the site of origin.
1.0.3 The causes of cancer
Cancer is basically a genetic disease even if there are some viral cancer types.
There are two differences between it and other genetic diseases:
1. Cancer is generally caused by somatic mutations whereas other genetic
disease arise as result of germ line mutations, although a sizable mi-
nority.
2. Each individual cancer appears to arise from several sequential muta-
tions (Multi-Hit or Multi-Stage theory of carcinogenesis)
A common general feature of carcinogenesis in both humans and experimental
studies is that a relatively long time period elapses between the application of
a carcinogenic stimulus and the emergence of clinically recognizable cancer.
This is known as the latent period and can be from few months to many
years. The most likely reason for the latent period is that carcinogenic agent
does not cause cancer in one step ,but rather genetically alters normal cell(s)
so that it enjoys a proliferative advantage over its normal neighbors. This
altered cell(s) then undergos clonal expansion driven by mutation, and the
resultant cell could be more susceptible to further changes. Accordingly,
1Histogenesis: the cellular origin of a tissue or a tumor.
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one of these cells later acquires a further mutation allowing its progeny to
overgrow its neighbors and perhaps form a small benign tumor. Further
phases of clonal expansion and mutation will eventually give rise to a cell
with a a sufficient number of mutations (’hits’) to bestow the malignant
phenotype upon cells arising from it, so that they invade surrounding tissue
and metastasize to other organs- thus multi-stage carcinogenesis.
Most carcinomas are rare under 30 years old but then the incidence rate
increases dramatically with age. The explanation is that 3 to 7 ’hits’ are
required for a cancer to form.
Initiators and promoters
There are two types of chemical involved in causing cancer:
1. Initiating agents: are ”genotoxic agents”, binding to DNA and causing
mutations. Their effects are irreversible.
2. Promoting agents: circumstances which ”promote” the expansion of
altered cells. They are ineffective in producing cancer on their own or
when given before the initiator.
Thus the process of chemical and irradiation-induced carcinogenesis are thought
to initially involve genotoxic events which irreversibly damage DNA (initia-
tors) followed by circumstances which promote the expansion of altered cells.
Such progeny could than be ’at risk’ of further mutation, leading to cycles
of initiation and promotion before emergence of the malignant phenotype.
The environment
The common fatal cancers occurs as a result of lifestyle and other environ-
mental factors and can be preventable. It is not surprising that the envi-
ronment is implicated in carcinogenesis, as the vast majority of tumors are
carcinomas arising from epithelium in direct contact with the environment.
Environmental risk factors fall into 3 categories:
1. Physical agents (X-ray,UV-light..)
2. Chemical agents
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3. Infectious agents (bacteria,fungi,virus)
Identifying the causes
Through a combination of epidemiological and experimental studies it has
been possible, with a reasonable degree of certainty, to identify certain agents
which have something to do with the carcinogenic process. Doll and Peto
(1981) suggested that there are three determinants for cancer development:
1. Nature: a person’s genetic make-up at conception.
2. Nurture: relates to what people do during their lives.
3. Luck.
We must observe that some occupations , medical and social hazards may
contribute to the developing of cancer. Years of research have brought to
light risk factors that increase people’s chances of getting particular types of
cancer. Some of these risk factors are inevitable, while others can be avoided
by choosing to live a healthy lifestyle. For example, smoking cigarettes is an
avoidable risk factor. Changing your lifestyle to get rid of unhealthy choices
such as smoking can be difficult to accomplish (tobacco is an addictive drug
and stopping smoking means beating that addiction), but the rewards are
real. Stopping smoking and similar healthy lifestyle changes will not insure
that you never get cancer, but they will reduce your cancer risk. This is true
whether you have never had cancer before, or if you have previously beaten
cancer and are wondering what you can do to reduce your chances of relapse.
It is important to note that cancer is not a uniform illness, but rather has
many forms. Each specific type of cancer is different and consequently has a
different set of associated risk factors.
Cancer caused by viruses
As we said at the beginning of this chapter, Cancer can be a genetic dis-
ease or a viral one.
The relationship between virus and cancer is becoming of profound impor-
tance as virus lifestyle inherently affect host cell DNA. Cancer causing viruses
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are called oncogenic viruses. Only 17-20 percent of human cancer is thought
to be associated with viruses. Oncogenic viruses are classified according to
wether they contain DNA or RNA in their genome. DNA viruses are the
major cause of human virally-induced cancers.
• DNA oncogenic viruses:
Such viruses encode proteins which interact with critical cellular growth
regulatory molecules sabotaging their function. (EBV,HBV,HPV..)
• RNA oncogenic viruses:
Only a family of RNA viruses called retrovirus 2 cause tumors. How
these retrovirus induce neoplasia 3 is not entirely clear but it may be
a combination of an impairment of the immune system to kill tumor
cells together with a stimulation of cell proliferation in uninfected or
infected immune competent or other cells.
Genetic basis of cancers
Proto-oncogenes are normal cellular genes encoding cytoplasmic and nuclear
proteins, responsible for the cell’s normal proliferation and differentiation
programmes. These genes encode a variety of proteins involved in mitoge-
nesis 4 and differentiation which are organized into a cascade of reactions.
For example, the oncogenic activity of the v-onc genes seems to be due to
either quantitative changes in the levels of expression or differences between
the viral and cellular homologues leading to the production of a protein with
oncogenic activity. More important probably, in the case of human tumors,
proto-oncogenes can be involved in tumorogenesis through point mutation
5, gene amplification 6 or chromosomal translocation 7. It is now gener-
2Retrovirus: is a virus whose genome is on the form of single-strained RNA and
requires the activity of reversal transcriptase to produce the appropriate DNA because
it can complete its intracellular life cycle by becoming incorporated into the DNA of the
infected host cell for replication.
3Neoplasia: the process of tumor formation.
4Mitogenesis: activity of initiating cell division.
5Point Mutation: mutation at one single base in a gene, resulting in coding for a
different amino acid at this location, thus producing a different protein.
6Gene Amplification: increase in gene copy number.
7Chromosomal Translocation: change of location of a gene either on the same
chromosome or to different chromosome; when aberrant can cause proximity of genes that
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ally believed that most human neoplasia results from abnormalities in the
proto-oncogene expression, genes whose normal function is to control cell pro-
liferation and/or differentiation; thus these genes become oncogenes (cancer-
causing). They may function as oncogenes because their protein product is
abnormal or there is a quantitative defect (too much or too little) in transcrip-
tion of the gene. Two fundamentally different genetic mechanisms appear to
be operative during tumor development:
• Enhanced or aberrant expression of proto-oncogenes.
• Loss or inactivation of tumor suppressor genes.
Oncogenes can be regarded as a foot on the accelerator in the drive toward
cell proliferation. Anti-oncogenes, better known as tumor suppressor genes
are, on the other hand, a foot on the brake, in that their protein products
appear to inhibit cell proliferation. So, the behavior of normal cells seems
to be regarded by growth promoting proto-oncogenes , counterbalanced by
the growth-constraining tumor suppressor genes. Alterations (point muta-
tions,gene amplification,insertional mutagenesis 8 ,translocation) that poten-
tiate the activities of proto-oncogenes create the oncogenes that promote
growth and the establishment of the malignant phenotype. Conversely, ge-
netic alterations in tumor suppressor genes result in a loss of growth restraint
normally imposed by the protein products of these genes. The end product of
these two events would seem to be the same- deregulated cell behavior (prolif-
eration and differentiation). However , accumulating evidence suggests that
the development of many malignant tumors requires both types of change in
the tumor genome.
1.0.4 Cancer Symptoms
Every type of cancer is different, and has a unique set of symptoms associated
with it. Some cancer symptoms are manifest outwardly, and are relatively
influence each other with overall deleterious effect.
8Insertional Mutagenesis: retroviral mechanism of cellular transformation. Virus
RNA is the template for provirus double-strained DNA and this, in its entirely, is inserted
into the host genome, causing mutation.
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easy to notice and identify (such as a lump in the breast for breast cancer, or
blood in the stool corresponding to colorectal cancer). Other symptoms are
observable, but harder to decipher. For instance, two of the major symptoms
for lung cancer are a bronchitis-like deep cough and excessive shortness of
breath. Few people would assume these symptoms were serious and fewer
would associate them with cancer. Still other forms of cancer produce no
observable symptoms until they are at a very advanced (and therefore hard
to treat) stage.
1.0.5 Cancer Diagnosis
A physician who suspects a patient may have a specific form of cancer will
perform a series of tests and procedures to diagnose (or rule-out) a cancer.
Commonly, doctors will collect a sample of tissue or fluid from the area
believed to contain a cancerous tumor so that it may be analyzed in the
laboratory under a microscope. This collection and observation procedure is
known as a biopsy. Often, performing a biopsy and analyzing the resulting
samples is the only way that doctors can accurately determine a diagnosis of
cancer.
1.0.6 Stages of cancer
Following a positive identification of cancer, doctors will try to establish
the stage of the cancer. Cancers are ranked into stages depending on the
specific characteristics that they possess; stages correspond with severity.
Determining the stage of a given cancer helps doctors to make treatment
recommendations, to form a likely outcome scenario for what will happen to
the patient (prognosis), and to communicate effectively with other doctors.
There are multiple staging scales in use. One of the most common ranks
cancers into five progressively more severe stages: 0, I, II, III, and IV.
• Stage 0 cancer is cancer that is just beginning, involving just a few
cells.
• Stages I, II, III, and IV represent progressively more advanced cancers,
characterized by larger tumor sizes, more tumors, the aggressiveness
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with which the cancer grows and spreads, and the extent to which the
cancer has spread to infect adjacent tissues and body organs.
Another popular staging system is known as the TNM system, a three di-
mensional rating of cancer extensiveness. Using the TNM system, doctors
rate the cancers they find on each of three scales:
• T stands for tumor size.
• N stands for lymph node involvement.
• M stands for metastasis (the degree to which cancer has spread beyond
its original locations).
Larger scores on each of the three scales indicate more advanced cancer. For
example, a large tumor that has not spread to other body parts might be
rated T3, N0, M0, while a smaller but more aggressive cancer might be rated
T2, N2, M1 suggesting a medium sized tumor that has spread to local lymph
nodes and has just gotten started in a new organ location.
Still another staging system, called summary staging, is in use by the Na-
tional Cancer Institute for its SEER program. Summary stages include:
• ”In situ” or early cancer (stage 0 cancer).
• ”localized” cancer which has not yet begun to spread.
• ”regional” cancer which has spread to local lymph nodes but not yet
to distant organs.
• ”distant” cancer which has spread to distant organs.
• ”unknown” cancer to describe.
1.0.7 Cancer treatments
Doctors prescribe cancer treatment regimens based on a variety of factors
specific to patients’ individual circumstance. These factors often include the
cancer’s stage (type, location, and size of the cancer being treated), as well
as patients’ age, medical history, and overall health. The doctor may also
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ask patients to specify their treatment preferences before determining an op-
timal treatment plan as far as their condition does not require emergency
intervention. In general, it is not a good idea to rush into a treatment plan
merely as a way to reduce the understandable anxiety of having a cancer
diagnosis.
Each form of cancer is different and calls for a different set of treatment ap-
proaches. The main stay of treatment is usually surgical resection combined
with systemic chemotherapy or localized irradiation. The use of multiple
treatment modalities is known as Adjuvant Therapy and the simultaneous
use of a number of anticancer drugs is referred to Combination Therapy.
Clearly, successful treatments of neoplastic disease largely depends on inflict-
ing the maximum damage on the tumor stem cells and the minimum damage
on normal tissue stem cells.
As we said before, there are two types of treatment:
• Chemotherapy: is one of the most commonly used methods to treat
cancer patients. It is commonly prescribed for patients whose cancer
is not localized but instead has possibly metastasized, or spread, to
various locations in the body. Chemotherapy can be used to reduce
the symptoms and pain associated with cancer as well as to slow the
growth of cancerous tumors. In some circumstances chemotherapy may
even kill spreading cancerous cells.
Chemotherapy utilizes a powerful combination of drugs that are either
taken by mouth or injected directly into the bloodstream. Drug doses
are commonly given in a repeating pattern over a set amount of time.
Treatment frequency and duration depend on the type of cancer each
patient has, and the manner in which the patient tolerates and responds
to the drugs. Chemotherapy drugs target cells in the body that divide
and grow quickly and are usually able to destroy these cells. Unfor-
tunately cancer cells are not the only cells in the body which divide
and replicate quickly. In addition to cancerous cells, chemotherapy
drugs also kill some regular healthy cells, causing side effects such as
the fatigue, nausea, and hair loss. To some extent, side effects can
be controlled or alleviated with other medications or by altering the
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schedule of chemotherapy treatments. Unfortunately, one of the major
obstacles to the ultimate success of cancer chemotherapy is the ability
of malignant cells to develop resistance to cytotoxic drugs. This may be
resistance to a single agent or multi-drug resistance to cytotoxic drugs
(MDR) which confers upon cells the ability to withstand to lethal doses
of many structurally unrelated agents.
• Radiation Therapy: is a method of treating cancer that utilizes ra-
diation energy. Radiation is most commonly used to treat localized
cancers as opposed to cancer that has spread throughout the body.
The goal of radiation therapy is to kill cancer cells or at least limit
their ability to grow and divide by damaging their genetic material.
Like chemotherapy, radiation therapy is not perfectly precise in its tar-
geting of cancer cells, and some normal, healthy cells can also become
damaged. Patients should not become too concerned about damage
to healthy cells, however. Doctors generally do a good job shielding
and protecting healthy cells surrounding cancer areas from radiation
damage. Also, healthy cells that do sustain damage during radiation
treatment are usually able to repair their genetic material when treat-
ment ends.
There are two main ways in which radiation therapy can be admin-
istered: externally and internally. When delivered externally, special
machines are used to project a focused beam of radiation into targeted
areas of tissue within the body. Internal radiation therapy involves
surgical placement of radioactive materials near cancerous tumors or
afflicted body areas. When placed internally, the source of radiation is
often sealed in a small compartment such as a catheter or capsule prior
to implantation.
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Chapter 2
Mathematical Models in cancer
research
There appears to be no branch of organized knowledge that cannot benefit
- at least to some extent - from the use of mathematical reasoning. Biology,
the science basic to cancer research, is intermediate between physics and
literature in the use which it makes of mathematics. Hence, mathematics
can be useful in at least some areas of cancer research and the application
of mathematical models to a series of contemporary topics related to the
understanding and treatment of cancer is possible.
2.1 Carcinogenesis models
Theoretical carcinogenesis deals with the ways in which malignant disease
comes into being. Its scope ranges from detailed molecular theories of the
nature of cancer to phenomenological descriptions of the probability of tu-
mor occurrence under specific conditions. The phenomenological end of the
spectrum provides the less ambitious goals and also lends itself more readily
to the application of mathematical models.
2.1.1 The age incidence pattern of cancer
A natural starting point for many descriptive mathematical models has been
the observed age-incidence pattern of human cancer. It is found that most
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adult cancers increase rapidly in incidence with increasing age. Each tumor
type has is own pattern of occurrence as a function of age which can be
modulate by lots of factors. In spite of this , some broad generalizations
are possible. For a wide class of human tumors the age incidence pattern is
found to conform to an equation of the form:
I(t) = Ctk (2.1)
where I(t) is the incidence rate at time t since birth, C,k are constants.
2.1.2 Initiation and promotion
Another very important finding that has influenced carcinogenesis modeling
is the observation of a distinction between initiation and promotion in the
causation of cancer by chemical carcinogens. It has been found that different
chemical substances may play different roles in bringing about a recognizable
tumor. Some theories have been proposed that incorporate this feature in
their quantitative description of carcinogenesis.
2.1.3 A single cell origin of cancer
A third general idea which is important for some of the models considered
here is the single-cell origin (monoclonality) of many human tumors. This
implies that all the cells of the tumor are direct descendants from a single cell
which has experienced malignant transformation and undertaken unlimited
proliferation.
2.1.4 The single-stage theory of cancer
The simplest approach to quantitative carcinogenesis models was developed
by Iverson and Arley in 1950. This has been reviewed by Whittemore (1978).
Suppose the carcinogenic transformation of a clonogenic cell required only a
single irreversible event to occur (events are envisaged as occurring sponta-
neously as well as being direct consequence of exposure to some carcinogens).
The rate l(t) at which normal cell are transformed into malignant cells is:
l(t) = s+ pC(t) (2.2)
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where: s is the probability of spontaneous transformation, C(t) is the con-
centration of carcinogen, p is a constant expressing the dose response rela-
tionship for the carcinogen.
If N cells are at risk and carcinogenic transformation occur in depletion of
number, the rate r(t) of generation of malignant cells per unit time is:
r(t) = (s+ pC(t))N (2.3)
For anyone of the transformed cells to give rise to a detectable tumor it
is presumed that it must proliferate until a detectable cell number Nd has
been produced. Iverson and Arley supposed that a transformed cell has a
probability β per unit time of dividing and that is independent on unit time
and concentration of carcinogen. They calculated on this basis G(t) , the
proportion of transformed cells whose time of detectability is less than t.
2.1.5 The multi-cell transformation theory
Suppose now that malignant transformation is not a single cell event but
requires the cooperation of several cells. If k cooperating cells are needed,
the rate at which the kth alteration occurs in the tissue is approximately
proportional to (NpC)ktk−1 where C = const is the concentration of the
carcinogen.
Whit some other simplifying assumptions it is found that the incidence rate
should be proportional to the kth power of carcinogen and (k − 1)power of
time. The observed age incidence curve could be interpreted to mean that
seven cooperating cells are necessary for the genesis of a tumor. The evidence
on monoclonality of tumors implies that it is unlikely to be true in general.
As a result interest has shifted to multistage theories which incorporate the
hypothesis of monoclonality.
2.1.6 The multistage theory of cancer
The multistage theory owes its conceptual origins to Muller (1951) and
Nordling (1954) and its mathematical formulation to Stocks (1953). The
central assumption of the multistage theory is that a single clonogenic cell is
transformed to a malignant state as a result of experiencing a sequence of k
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events, no one of which can bring about transformation on its own. These
may be thought of as being a sequence of k somatic mutations affecting DNA,
although this interpretation is not a necessary one. Consider k stages or steps
through which a cell must pass sequentially in order to reach the end state or
full blown malignant transformation. Let λ1, λ2, ......, λk be the probabilistic
rate constants for entering to a state from the immediately preceding state.
The probability that the first event has not occurred by time t is e−λ1t. The
probability that the second event is not occurred given that the first is oc-
curred is e−λ2t(1 − e−λ1t) and so on k terms. The probability of malignant
transformation of any cell by time t or less is given by:
P (t) =
k∏
j=1
[1− e−λjt] (2.4)
provided that successive stages of transformation are mutually independent.
Now, since malignancy transformation is rare, λi will be very small and we
may write:
e−λjt u (1− λjt) (2.5)
hence
P (t) = Aλ1λ2...λkt
k (2.6)
where A is a compound constant (a function of the λ terms).
If there are N cells at risk in the tissue, the age specific incidence rate may
be equated to the product of the cell number and the rate of change P (t).
I(t) = N
dP (t)
dt
= NAλ1...λkkt
k−1 = Bλ1λ2...λkt
k−1 (2.7)
The general form of multistage theory is consistent with monoclonality , the
dorm of age-incidence curves and the initiation-promotion phenomenon.
2.1.7 Epigenetic formulation of the multistage theory
It is not necessary to visualize the k states of the multistage theory as cor-
responding to a sequence of DNA mutations. An epigenetic version of the
theory was developed in 1977 by Watson, involving gene-switching networks
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rather than point mutations and was invoked to make the math model consis-
tent with the biological idea that malignant change might involve a derange-
ment of the cellular differentiated state rather than a series of conventional
mutations.
2.2 Models of tumor growth
The capacity for progressive growth is one of the most conspicuous prop-
erty of a malignant tumor once established. Many tissues are in a long-term
steady state of cell renewal in which proliferation and cell loss are in equilib-
rium. Many are also capable of sustained periods of regrowth or regeneration
following injury during which the rate of proliferation greatly exceeds the cell
loss rate. All normal tissues, however, cease net growth when cell numbers
have been restored to the original level or close to it. This behavior suggest
a feedback mechanism of some kind. Tumor differs in that the equilibrium
level is unattainable or is set so high as to be incompatible with the survival
of the host. The regulation of growth control is a very mysterious process.
It has been known for a long time that the rate of tumor growth differs be-
tween tumors and varies with time for a single tumor. So, it is generally
misleading to derive any ’general pattern’ of tumor growth; but it is evident
that some models of growth occur more commonly than others. It is perhaps
not unreasonable to think of typical growth patterns rather than universal
or general ones, keeping in mind that some tumors may follow individualistic
growth patterns that are quite untypical. With these reservations in mind
consider now the simplest possible picture of how a tumor grows. Suppose
a tumor at time zero is composed of N0 cells which divide regularly with a
time interval Tc between successive doublings. Assuming the cells are not
synchronized , there will be an ongoing increase in cell number given by
N(t) = N02
t
Tc (2.8)
log2(
N(t)
N0
) =
t
Tc
(2.9)
This exponential growth pattern is the simplest which it is reasonable to
consider. In more complex cases, the doubling time, usually denoted TD ,
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will not be identical with the interdivision time Tc though there will usually
be a close relation between them.
2.2.1 The Gompertz growth model
For tumor following decelerating growth curves, a variety of empirical mathe-
matical descriptions have been used to describe the growth mode. Gompertz
equation dates back to B.Gompertz who, in 1825, first used it in the context
of actual statistics. However, the Gompertz model owes its present popular-
ity to Laird (1964) who developed its use as a growth model.
The algebraic form of the Gompertz equation, applied to a growing cell pop-
ulation, states that:
N(t) = N0exp(
αN0
β
[1− exp(−βt)]) (2.10)
where N(t) is the cell population at time t, N0 the population at time t0 and
αN0 and β are kinetic parameters characteristic of the tumor concerned.
The parameter αN0 corresponds to the instantaneous specific growth rate of
N0 cells at time zero, if N0 is the starting size of the tumor at time origin.
The parameter β provides a measure of how rapidly the curve departs from
a simple exponential and curves over to assume its characteristic shape.
The model implies a limiting cell number N∞ which the tumor cell population
will approach asymptotically:
N∞ = limt→∞N(t) = N0exp
αN0
β
(2.11)
In most cases N∞ is so large that the tumors burden result in death of the
host long before it is reached. It is best regarded as a match abstraction not
physically achievable.
The Gompertz equation may be written in a variety of ways. One is the
equation represented an exponentially growing cell population whose specific
growth rate parameters itself declined with time:
dN(t)
dt
= α(t)N(t) (2.12)
with
N(0) = N0 (2.13)
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and
dα(t)
dt
= −βα(t) (2.14)
with
α(0) = α0 (2.15)
However, it is intuitively unreasonable that the specific growth rate parame-
ter α(t) should be a function of clock time. More likely, α(t) depends on some
other set of biological variables, and the time dependence arise indirectly.
The Gompertz model is best formulated as differential equation represent-
ing the instantaneous rate of change of tumor cell number with time. A
differential equation formulation is in fact the most natural and general rep-
resentation of a growth model. It has the advantage that perturbations of
growth can be incorporated by addition of appropriate terms to differential
equation.
The equation
dN(t)
dt
= βN(t)ln(
K
N(t)
) (2.16)
is a non-linear differential equation which can be shown to yield the Gompertz
algebraic equation on integration.
2.2.2 Tumor growth during latency
All the actual data considered were for the observable phase of growth. The
question of how tumors really grow during ”latency” is an important one.
Some indirect evidence suggesting that Gompertz curves do not provide an
accurate representation over the whole growth range. Evidence that is so
comes from studies of the relationship between the number of tumor cells
implanted in an experimental animal and the time for the resultant tumor
to become detectable (the latent period). Suppose growth following implan-
tation of N0 cells is exponential with constant specific growth parameter α0.
If N is the cell number at which the tumor fist becomes detectable and τ the
latent period we have:
N ′ = N0exp(α0τ) (2.17)
or
τ =
1
α0
[ln(N ′)− ln(N0)] (2.18)
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Now suppose the growth follows Gompertz kinetics with parameters αN0 and
β then:
N ′ = N0exp(
αN0
β
[1− exp(−βτ)]) (2.19)
which gives, on rearrangement,
τ = − 1
β
ln(1− β
αN0
ln(N ′))− 1
β
ln(
β
αN0
ln(N0)) (2.20)
In almost all cases studied, the experimental data support the exponential
model of growth delay during latency. The implications of these findings is
that tumor growth from one cell upwards must be considered in at least two
phases: exponential growth during latency and Gompertz kinetics during the
observable phase.
2.2.3 The ’Gomp-Ex’ growth model
Studies suggested that tumors initially follow an exponential growth pattern
which gives rise to a Gompertz pattern after some critical cell number NC has
been reached. This suggest a composite ” Gompertz- exponential ” growth
model described by a piecewise-continuous differential equation:
1
N(t)
dN(t)
dt
=
{
λ ifN 6 Nc
λ− βln(N(t)/Nc) ifN > Nc
(2.21)
where Nc is tumor cell number at which transition between growth model
occurs.
The integrated form of ’Gomp-ex’ equation is
N(t) =
{
N0exp(λt) ifN 6 Nc
Ncexp(
λ
β
(1− exp[−β(t− tc)])) ifN > Nc
(2.22)
where
tc =
1
λ
ln(
Nc
N0
) (2.23)
represents the time to reach Nc from the initial starting size.
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2.2.4 A stochastic version of the Gompertz growth
model
As a modification of the Gompertz model, Speer et al (1984) introduced a
stochastic component. They suggested that the theoretical population limit
N∞ was pre-set as a mutational property of the cells concerned and could be
changed by further mutations which were envisaged as taking place randomly
over time. An important aspect of these stochastic growth models is that
active growth takes place in a series of spurts with intermediate periods
during which the tumor is close to the asymptotic limit.
2.2.5 Alternative models for growth retardation
All these models incorporates the feature that tumor growth occurs more
slowly as some limit is approached. The cause of this is that growth of a
tumor cell population reflect the net balance of tumor cell production and
tumor cell loss. Retardation of growth with increasing size might than be
attributed to lesser cell production , increased losses or both. Other models
have been created but we will not discuss them here.
2.2.6 Compartmental model based on cellular differ-
entiated state
The existence of differentiated cells warrants attention in the construction
of growth models. The simplest kinetic picture of a differentiating tumor
assigns tumor cells to one of the three compartments:
1. True tumor cells with full clonogenic potential (immortal stem cells in
proliferative normal tissues).
2. Cells which have begun differentiation.
3. Differentiated cells, no longer capable of cell division.
As a first simple model we may assume there is constant probability per
unit time of a clonogenic cell being induced to differentiate (proportional to
the size of the clonogenic compartment). Once induced, differentiated cells
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move through the intermediate developmental stage in programmed fashion
in fixed time. Loss may be either random or result from programmed ageing
(we assume random losses).
These conditions give rise to a compartmental model:
dN1(t)
dt
= H[t, N1, N2, N3]N1(t)− ω1N1(t)− F (t) (2.24)
dN2(t)
dt
= F (t) + (α− ω2)N2(t)− exp[(α− ω2)τ ]F (t− τ) (2.25)
dN3(t)
dt
= exp[(α− ω2)τ ]F (t− τ)− ω3N3(t) (2.26)
where N1(t) represents the number of clonogenic cells with proliferative
rate α0 and loss rate ω1, N2(t) represents the number of developing cells
with proliferative rate α and loss rate ω2, N3(t) represents the number of
differentiated cells with loss rate ω3, H is a mathematical function. We have
supposed the rate of loss of clonogenic cells due to induction of differentiation
is directly proportional to clonogenic cells number:
F (t) = µN1(t) (2.27)
Thus we have:
dN1(t)
dt
= H[t, N1, N2, N3]N1(t)− (ω1 + µ)N1(t) (2.28)
dN2(t)
dt
= µN1(t) + (α− ω2)N2(t)− exp[(α− ω2)τ ] (2.29)
dN3(t)
dt
= µexp[(α− ω2)τ ]N1(t− τ)− ω3N3(t) (2.30)
Clearly, solutions depend on H, specific proliferative rate of clonogenic cells.
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2.3 Models for tumor response to chemother-
apy
Cancer chemotherapy is a very much more complex treatment modality to
consider than radiotherapy. This is because chemotherapy is not a single
modality at all but a collective name for as many modalities as there are
anti-cancer drugs. Commonly, several drugs, often with different modes of
action, are used together in combination regimes and are more effective than
treatment using single agents. These features do not make cancer chemother-
apy a very promising subject for mathematical modeling. Quantitative mod-
eling has the potential to be useful but is likely to require knowledge of
the numerical values of large numbers of parameters necessary to charac-
terize combination chemotherapy regimes. This information is very seldom
available, consequently , though a considerable literature has grown up on
mathematical modeling in cancer chemotherapy, this had a significant impact
on clinical treatment in only a few cases.
2.3.1 Drug Action
The spectrum of drugs now available in cancer chemotherapy sterilize cells
by a variety of mechanisms. An important class of drugs, alkylating agents
achieve their major effects by cross-linking DNA [DH09]. Another important
group of drugs are the metabolic inhibitors which selectively interfere with
particular enzymes. The antibiotic actinomycin D has found some applica-
tion in cancer chemotherapy, it is thought it achieves its cytotoxic effect by
inhibiting the transcription of RNA to DNA. These examples show a few of
the different mechanisms by which anti-cancer drugs kill cells. It is generally
not known why some drugs are more effective than others in treating cancer.
In practice, the most important criterion for drug classification is in terms
of their cycle specificity. Most anti-cancer drugs are more toxic to rapidly
proliferating cells than resting G0 cells [DH09]. However, this cell kinetic
differential varies greatly in magnitude between drugs. For alkylating agents
and similar drugs, cycle specificity of action is not very pronounced; we can
call such drugs cycle-non-specific. For other drugs, the difference between
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the sensitivities of cycling and non cycling cells is much greater. These drugs
are often called cycle-specific. In terms of tumor response to chemotherapy
is important this distinction.
A great consideration in cancer chemotherapy concerns the drug dose to tu-
mor and to critical normal tissues. A natural fist step in determine the ”right
dose” would be to find drug concentration as a function of time for each rele-
vant tissue as well as tumor. This is the subject of pharmacokinetics in which
mathematical models often play a useful role, usually representing important
tissues or body regions as a series of compartments and formulating differ-
ential equations to describe the movement of drug from one compartment to
another.
I will now consider mainly the general principles of how cancer chemotherapy
works assuming that drug concentrations are usually known.
2.3.2 Exposed cells and effects of chemotherapy
• Normal Tissues:
Usually cancer chemotherapy is given systemically; all normal tissues
and organs will be exposed to the drug and any of them may be injured.
It’s fundamental to consider normal tissue damage as a constraint that
must be built into any model used to predict optimum schedules. The
effectiveness of chemotherapy over normal tissues depends on the in-
tensity with which therapy can be given. Some chemotherapy drugs
are very diverse and tissues may be dose-limiting for different drugs
or drug combinations. At the present to little is known about math-
ematical dose-response relationships for normal tissue toxicity so it is
difficult to apply general models; some empirical rules have been found
in practice but they do not usually take analytical form which leads to
prediction of tolerance doses when the schedule is changed.
• Tumoral cells:
Rapidly growing tumors are usually the most responsive to cancer
chemotherapy. This is probably due to the cycle-specific mode of action
of many chemotherapeutic drugs.
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2.3.3 Cycle non-specific chemotherapy of a tumor cell
population conforming to Gompertz kinetics
Recall:
Gompertzian growth of an untreated tumor cell population may be described
by the non-linear differential equation:
1
N(t)
dN(t)
dt
= αN0 − βln(
N(t)
N0
) (2.31)
where αN0 , β are kinetic parameters. In equivalent form:
1
N(t)
dN(t)
dt
= −βln(N(t)
N∞
) (2.32)
where N∞ = N0exp(
αN0
β
) and represents the theoretical maximum size to
which the growth curve is asymptotic.
Consider now the effect of exposing the tumor cell population to a cycle-
non-specific drug at concentration C(t). For the case of an exponential dose-
response relationship between drug concentration and rate of cell killing, we
may write
1
N(t)
dN(t)
dt
= −βln(N(t)
N∞
)− λC(t) (2.33)
provided the cells sterilized by the drug disappear quickly from the popula-
tion. The solution depends on the functional form of the drug concentration
C(t). In many real situations C(t) would be obtained by interpolation from
measurement of drug concentration in blood or by solution of pharmacoki-
netic model (by numerical integration).
Considering the idealized case where drug concentration remains constant
throughout the time of interest C(t) = C(0) we have
1
N(t)
dN(t)
dt
= −βln(N(t)
N∞
)− λC(0) (2.34)
which can be solved by change of variable leading to
log(
N(t)
N(0)
) = (
αN0
β
− λC0
β
)[1− exp(−βt)] (2.35)
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It is useful to compare this equation with the algebraic expression for Gom-
pertzian growth of an untreated cell population
log(
N(t)
N(0)
) =
αN0
β
[1− exp(−βt)] (2.36)
Equations (2.35) (2.36), have the same form.
For low drug concentrations the term (
αN0
β
− λC0
β
) is positive and the tumor
continues to grow, more slowly than in the untreated case. A new asymptotic
limit, depending on drug concentration, N∞(C0) can be defined. Equation
(2.35) can be rewritten
N(t) = N(0)exp[(
αN0
β
− λC0
β
)[1− exp(−βt)]] (2.37)
therefore
N∞(C0) = limt→∞(N(t)) = N∞exp(
−λC0
β
) (2.38)
For higher drug concentrations the term (
αN0
β
− λC0
β
) is negative, the asymp-
totic limit N∞(C0) will be less than the initial cell number N0 and the tumor
does not grow but regress.
2.3.4 Cycle-specific therapy
Changing loss factor
In the case of cycle-specific therapy the analysis differs. First consider the
case where the growth fraction remains constant and retardation is entirely
due to changing loss factor.
The most important factor is the proportion of cycling cells. Assume the
growth fraction f to be constant. Then, in the presence of cycle-specific
drug we have
1
N(t)
dN(t)
dt
= −βln(N(t)
N∞
)− fµC(t) (2.39)
where µ is the appropriate drug sensitivity parameter. In this case only pro-
liferation cells are vulnerable to cycle-specific therapy in fact the parameter λ
is replaced by fµ. The decline of tumor cells number follow the same pattern
as for cycle-non-specific drug.
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Changing growth fraction
Now consider the case where Gompertz retardation is entirely due to a chang-
ing growth fraction. In this case the growth fraction f(t) is not constant but
varies with cell population size. If C(t) is the concentration and K(t) the
rate of cell kill due to a cycle-specific drug, we have
K(t) = µf(t)N(t)C(t) (2.40)
where µ is the sensitivity parameter for the effect of the drug on cycling cells.
Thus we have
1
N(t)
dN(t)
dt
= −βln(N(t)
N∞
) (2.41)
1
N(t)
dN(t)
dt
= λf(t) (2.42)
where λ is the specific growth rate for constantly cycling cells.
Equating last two we obtain the following expression for instantaneous growth
fraction f(t):
f(t) =
β
λ
ln(
N(t)
N∞
) (2.43)
which allows to represent the effects of cycle- specific killing agent
1
N(t)
dN(t)
dt
= −βln(N(t)
N∞
)− µf(t)C(t) (2.44)
= −βln(N(t)
N∞
)− µ[−β
λ
ln(
N(t)
N∞
)]C(t) (2.45)
= −βln(N(t)
N∞
)(1− µ
λ
C(t)) (2.46)
and to find the critical drug concentration to initiate depopulation. This
requires
1
N(t)
dN(t)
dt
< 0 (2.47)
Therefore
1− µ
λ
C(t) < 0 (2.48)
or
C(t) >
λ
µ
(2.49)
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This condition is independent of cell population size. This means that a
drug concentration sufficient to initiate depopulation should be sufficient to
maintain it. The phenomenon of Kinetic resistance 1 cannot occur in this
situation.
It is also informative to consider the case of constant drug concentration
C(t) = C(0). This gives for equation (2.46),
1
N(t)
dN(t)
dt
= −βln(N(t)
N∞
)(1− µC0
λ
) (2.50)
This may be integrated to give
ln(
N(t)
N0
) = (−ln(N∞))(1− exp[β(
µC0
λ
− 1)t]) (2.51)
which is a function whose decline accelerates with time, provided the drug
concentration C0 conforms to inequality (2.49) and therefore is sufficient to
initiate depopulation in the first place.
It must be noticed that this model incorporates the implicit assumption that
the growth fraction of the tumor cell population responds instantaneously to
cell killing by chemotherapy.
1Kinetic resistance means that a chemotherapy schedule which initiates depopula-
tion may nevertheless fail to achieve tumor cure, however long treatment is continued.
Consider the drug concentration level which produce a rate of cell kill just sufficient to
balance cell repopulation. Let this critical concentration be C
(c)
0 . Then if C0 < C
(c)
0 a net
depopulation would occur and the tumor will regress. For a tumor cell population whose
growth conforms to Gompertz kinetics, treated by cycle-non-specific drug, the net rate of
change is given by 1N(t)
dN(t)
dt = −βln(
N(t)
N∞
)−λC(0). If the drug concentration is just suffi-
cient that the rate of cell kill balances rate of repopulation we have: 1N(t)
dN(t)
dt |C=C(c)0 = 0
so that −βln(N(t)N∞ ) = λC
(c)
0 . Therefore, at any instant, the requirement for depopulation
to proceed is that C0 > C
(C)
0 that is C0 > −
β
λ ln(
N(t)
N∞
). This means that the condition to
initiate tumor cell depopulation is itself a function of population size. The drug concen-
tration to initiate depopulation is larger the smaller the population size. A corollary is
that the drug concentration to maintain depopulation will become larger as the population
shrinks. The possibility than arises that drug concentration which initiates depopulation
will not be sufficient to maintain it which is the meaning of Kinetic resistance.
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The general case
Last consider the case where Gompertz retardation is not exclusively due
either to changing loss rate or changing growth fraction but a mixture of the
two:
1
N(t)
dN(t)
dt
= λf(t)− L(t) (2.52)
1
N(t)
dN(t)
dt
= −βln(N(t)
N∞
) (2.53)
Equating (2.52) and (2.53)
λf(t)− L(t) = −βln(N(t)
N∞
) (2.54)
Hence
f(t) =
1
λ
[L(t)− βln(N(t)
N∞
)] (2.55)
Evaluate this in explicit terms requires knowledge of loss function L(t); no
general solution is possible for this case. Intuitively, it seems reasonable
that if the retardation is mainly due to loss-factor changes then kinetic resis-
tance would occur, but if the retardation is mainly due to a changing growth
fraction, the kinetics of depopulation would be accelerating in form. Inter-
mediate situations are possible, it may not be possible to reach clear-cut
conclusions.2.
2It is not difficult to see how the results would be modified if we assume ’Gomp-ex’
kinetics instead of Gompertz one. For more detailed explanation see [Whe98]
57
58
Chapter 3
Modeling tumor-immune
system competition
The complex and non-linear interplay of the immune system (IS) with non-
self entities offers and ideal area of research and has long been a source of
great interest for physicists. In particular, the interaction of IS with tumors
is a classical challenge in the world of biophysics.
Molecular biology has shown that tumor cells (TCs) are characterized by
a vast number of genetic events leading to the appearance of specific anti-
gens, which trigger action by the IS. These experimental observations have
provided a theoretical basis to the old empirical hypothesis of immune surveil-
lance i.e that the IS may act to control or eliminate tumors. Only in recent
years, experimental and epidemiologic evidence has been accumulated in fa-
vor of the hypothesis and it has been demonstrated that the IS can suppress
tumors. The competitive interaction between TCs and the IS, involves a con-
siderable number of events and molecules, and as such is extremely complex
and, as a consequence, the IS is not able to eliminate a neoplasm in all cases,
which may escape from IS control. Of course, a dynamic equilibrium may
also be established, such that the tumor may survive in a microscopic steady
state (MISS), which is undetectable by diagnostic equipment. However, con-
sider a tumor which is constrained by the IS in a MISS. Over a long period of
time (a significant fraction of the mean life span in men), the neoplasm may
develop multiple strategies to circumvent the action of the IS , which, in the
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long term, may allow it to evade immune surveillance and to re-commence
growing to its carrying capacity . The tumor has adapted itself to survive in
a hostile environment, in which antitumor immune response is activated. In
other words the immunogenic phenotype of the tumor is ”sculpted” by the
interaction with the host’s IS. For this reason, the theory of IS-Tcs interac-
tion has been called immunoediting theory by Dunn et al.
Finally, the study of the interaction tumor-immune system led to the pro-
posal and implementation of an interesting therapeutic approach: the im-
munotherapy, consisting in stimulating the IS in order to better fight, and
hopefully eradicate, a cancer. The basic idea of immunotherapy is simple
and promising, but the results obtained in medical investigations are glob-
ally controversial, even if in recent years there has been evident progress.
Coming to the mathematical way to model the above interactions, the ba-
sic idea of the ecological modeling of TCs-IS interaction is simple: TCs and
effector cells (ECs) of IS are seen as two competing populations. TCs are
mainly the prey of the ECs, whose proliferation is stimulated, in turn, by the
presence of TCs. However, TCs also induce a loss of ECs; and there is an
influx of ECs, whose intensity may depend on the size of the tumor. Based
on this simple scheme and on its generalizations, many works have appeared
using a finite dimensional approach based on specific models with constant
or tunable parameters (and references therein).
However an approach based on a specific model is in contrast with the poly-
morphic nature of cancer, and it does not allow easily to catch the general
features of the TC-IS interaction.
We now propose and investigate a family of models, which admits as partic-
ular cases some well known mathematical models of tumor-immune system
interaction, with the additional assumption that the influx of immune system
cells may be a function of the number of cancer cells.
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3.1 A general family of models and its prop-
erties
A very interesting Volterra-like model for the interaction between a popula-
tion of tumor cells ,whose number is denoted by (X), and a population of lym-
phocyte cells,whose number is denoted by (Y ) was proposed by Sotolongo-
Costa et al.[OCCR03]:
X ′ = aX − bXY (3.1)
Y ′ = dXY − fY − kX + u+ P (t) (3.2)
where the tumor cells are supposed to be in exponential growth (which
is, however, a good approximation only for the initial phases of the growth)
and the presence of tumor cells implies a decrease of the ”input rate” of
lymphocytes. In non-dimensional form [OCCR03]:
x′ = αx− xy (3.3)
y′ = xy − 1
α
y − kx+ σ + p(t) (3.4)
(in short notation (x′, y′) = C(x, y)).
The function p(t) ≥ 0 is assumed periodic with period T and it models the
effect of immunotherapy.
The model shows two equilibria (one of which is tumor-free) and also un-
bounded growth. However, the systems allows negative solutions for non-
small x, which is not physically acceptable. In fact:
C(x, 0) = αx, σ + p(t)− kx (3.5)
implies that for x > (σ+pmax)
k
it is C(x, 0) = (0,−1) > 0, and y(t) becomes
negative in finite times. Furthermore, the second equilibrium point is a
consequence of the negativity of σ − kx.
The model in [OCCR03], though it has this problem of lack of physical
consistency, is, however, of great interest because the killing of lymphocytes
is seen as function of the x variable. Alternatively, the influx of lympho-
cytes may be thought of as a function of the entity of the disease, which we
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will denote as Q(x). Indeed, it has been observed that in some cases can-
cer progression may cause generalized immunosuppression [J.S01]. Thus in
[OCCR03], Q(x) = σ(1− (k/σ)x), which may be read as a first order Taylor
approximation of a more general non-increasing function.
However, a general influx function is only one of the possible modifications
of models: there may be others, which are also biologically reasonable. One
might take into the account many factors: different functional forms for
the interaction term, saturation in the predation term and, mainly, non-
exponential growth of the cancer: logistic, Gompertzian, generalized logistic,
etc. All these modifications are reasonable and useful.
Thus, it might be useful to define and study the following general family of
models:
x′ = x(αf(x)− φ(x)y) (3.6)
y′ = β(x)y − µ(x)y + σq(x) + θ(t) (3.7)
where:
• x and y are the non-dimensionalized numbers of, respectively, tumor
cells and effectors cell of immune system;
• 0 < f(0) ≤ +∞, f ′(x) ≤ 0 and in some relevant cases we shall suppose
that it exists an 0 < x̄ ≤ ∞ such that f(x̄) = 0, limx→0+xf(x) = 0.
Thus, f(x) summarizes many widely used models of tumor growth
rates, such as the Exponential model: f(x) = 1 [Whe98], the Gompertz:
f(x) = log(A
x
) [Whe98] and its generalizations [Whe98].
• φ(x) > 0, φ(0) = 1, φ′(x) ≤ 0 and xφ(x)→ l ≤ +∞;
• q(x) is such that q(0) = 1 (as a consequence σ = Q(0)) and it may
be non-increasing or also initially increasing and then decreasing, i.e.
we may assume that either the growth of tumor decreases the influx of
immune cells or that, on the contrary, it initially stimulates the influx;
• β(x) ≥ 0, β(0) = 0 and β′(x) ≥ 0;
• µ(x) > 0 and µ′(x) > 0.
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For the sake of simplicity we define the following function Ψ(x) =
µ(x)− β(x) and write:
x′ = x(αf(x)− φ(x)y) (3.8)
y′ = −Ψ(x)y + σq(x) + θ(t). (3.9)
Ψ(x) is assumed to be positive, otherwise it may be positive in
[0, x1)
⋃
(x2,+∞) with Ψ(x1) = Ψ(x2) = 0. We may assume that it
has an absolute minimum in [0,+∞). We may use Ψ(x) to classify the
tumors depending on their degree of aggressiveness against the immune
system:
• Ψ(x) > 0: in such a case the ability of destroying immune cells is never
won by the stimulatory effect on the immune system, therefore the
tumor may be indicated as ”highly aggressive”/”lowly immunogenic”;
• Variable sign of Ψ(x): since in such a case the destruction of cells may
be compensated by the stimulatory effect, we will refer to such a tumors
as ”lowly aggressive”/”highly immunogenic”.
Note that Nani and Freedman proposed an interesting model of adop-
tive cellular immunotherapy in which generic functions are used [F.N00].
However, their approach differs from ours since in their model the prolif-
eration of cells of the immune systems is not stimulated by cancer cells.
In other words in the Nani and Freedman model the interaction tumor
cells-immune system is only destructive for immune cells. Furthermore, in
their model the ’loss rates’ are proportional (in our notation we might write
µ(x) = µ(0) + constφ(x)).
In the absence of treatment, systems (3.8) and (3.9) admits the existence
of a cancer free equilibrium CF = (0, σ
Ψ(0)
).
If f(0) < +∞, we have that if σ > σcr = αΨ(0)f(0)φ(0) CF is locally asymptotically
stable (LAS), unstable if σ < σcr. Biologically, σ > σcr means that the
immune system works very well and that it is able to destroy small tumors.
On the contrary σ ≈ 0 means that there is immunodepression.
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Furthermore, when φ(x) = constant = ϕ and Ψ(x) ≤ Ψ∗ < ∞ if
σ > σ∗ = αf(0)Ψ
∗
(qminϕ)
it follows that CF is globally asymptotically stable (GAS).
In fact, from y′ = −Ψ(x)y+σq(x) ≥ −Ψ∗y+σqmin it follows that asymptoti-
cally y(t) ≥ σqmin
Ψ∗
As a consequence, asymptotically x′ ≤ (αf(0)−ϕ(σqmin
Ψ∗
))x,
i.e. if σ > σ∗ it is x(t)→ 0⇒ y(t)→ σ
Ψ(0)
.
A relevant problem, up to now, is that the immunotherapeutic agents are
characterized by strong toxicity, thus σ > σ∗ might be too biologically
high,even in cases in which it is mathematically small.
If f(0) = +∞, as in the Gompertzian case and in other tumor growth
models, then CF is unstable anyway because in such a cases the derivative
of xf(x) at x = 0 is +∞. In the light of our generalization, this implies that
the immune system would never be able to totally suppress even the small-
est tumor cell aggregates, which is a very strong inference. This instability
result deserves some comments because it has deep medical implications:
the impossibility to completely recover from any type of tumors whatsoever.
On the contrary, it is commonly held that the immune system may be able,
in some cases, to kill a relatively small aggregate of cancer cells. In the
background of all cancer therapies (which are of finite duration) there is the
implicit hypothesis that the drug will kill the vast majority of the malignant
cells and that the relatively few residual cells may in some cases be killed by
the immune system. Accepting this hypothesis, the equilibrium CF should
have the possibility to be LAS and, as a consequence, for small x the function
f(x) should be bounded.
The modeling of cancer by means of the Gompertz law of growth was in-
troduced in early sixties by Laird [Lai64], [Lai65]. She conducted pioneering
data-fitting work using a vast amount of real data and justified the law in
terms of increasing mean generation time. There is much research showing
that the Gompertzian model fits data well from experimental and in vivo
tumors [I.D94, JtA94, A.M94, IM03]. From a theoretical point of view, Gyl-
lenberg and Webb [M.G89], Calderon and Kwembe [CC91], Calderon and
Afenya [E.K00, E.K04] proposed physico-mathematical justification of the
Gompertz model. Furthermore, some interesting physical properties of the
Gompertz model have been elucidated by Konarski and Molski [M.M03] and
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by Konarski and Waliszewski [P.W03]. However, the doubling time of a
population of cells cannot be lower than the minimal time needed by a cell
to divide, which is obviously non-null. This biological constraint is in con-
trast with the unboundedness of f(x) in the Gompertz and other models, as
stressed by Wheldon [Whe98]. More recently, inconsistency at low number
of cells have been recognized by Castorina and Zappala’ in their deriva-
tion of the Gompertzian model based on methods of statistical mechanics
[P.C04b, P.C04a]. They showed that the validity of the Gompertz model
starts above a minimum threshold for the number of cells, whereas under the
threshold there is exponential growth. In other words, they derived biophys-
ically the Gomp-Ex model proposed in the second chapter [Whe98]. Using
data from multicellular tumor spheroids, Marusic et al. performed a sys-
tematic comparison of many models [JSP94], which showed that Gompertzs
model fitted their data very well, but slightly less well than the Piantadosi
model [S.P85], which has finite f(0). Furthermore, in their fittings, it was not
possible to discriminate between the pure Gompertz model and the Gomp-
Ex model. Demicheli et al. used Gomp-Ex model on in vitro and in vivo
data obtaining results strongly supporting this model [CM89]. Moreover, in
general,van Leeuwen and Zonneveld [IL01] claims that it may be not possible
to discriminate between exponential, logistic and Gompertzian models in the
early phases of growth. Recent experimental studies conducted by Bru and
coworkers support an initial phase of exponential growth [GAI03]. Summa-
rizing, the results by de Vladar and Gonzalez are valuable, but they may be
read in a dichotomic way:
• A tumor is permanent: the innate immune surveillance is never able to
completely eradicate even the smallest tumor.
• Since there is relevant evidence that the immune system is able in some
cases to eliminate small tumors [GR02, G.P04] (the ability of eradicate
the disease or not depends on initial conditions), the properties of the de
Vladar Gonzalez model may be seen as an evidence that Gompertzian
and other models characterized by f(0) = +∞ are not appropriate
for very small tumors, (in coherence with [Whe98, P.C04b, P.C04a,
GAI03]).
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In case of the absence of influx of immune cells (q(x) = 0) and for laws
of growth in which x̄ exists,there is a different particular equilibrium point,
which we shall call ”immune free”: IF =(x̄,0), which is LAS.
Other multiple non-null equilibria may be found by finding the positive
intersection of the two nullclines:
yc(x) = α
f(x)
φ(x)
(3.10)
yI(x) =
σq(x)
Ψ(x)
(3.11)
The functions yc(x) and yI(x) are useful in the determination of the LAS
of the equilibria , since the characteristic polynomial of the Jacobian, calcu-
lated at a given equilibrium point (xe, ye), is:
λ2 +(Ψ(xe)−xeφ(xe)y′c(xe))λ+Ψ(xe)xeφ(xe)(−y′c(xe)+y′I(xe)) = 0. (3.12)
So the LAS condition is:
y′c(xe) <
Ψ(xe)
xeφ(xe)
AND
y′I(xe) > y
′
c(xe)
Note that the first part of the AND condition is automatically fulfilled
when y′c(x) = 0 (because xe cannot lie in an interval where Ψ(x) < 0),
whereas the second part has a straightforward geometrical interpretation.
Finally, it is interesting to note that the above family of model may admit
limit cycles if f(x) = 1 (exponential growth) and q(x) is identically null for
x > xq with xq < x1. In fact, in such a case there is the equilibrium point
(x1, α) whose characteristic polynomial is:
λ2 + h2 = 0 h2 := −x1Ψ′(x1)α > 0
In effect, some cases of sustained oscillations (or slow oscillations with
very small damping) have been reported in the medical literature [B.J70,
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H.T97]. Periodic solutions in absence of influx of immunocompetent cells are
also predicted [D.K98].
On the contrary, if y′c(x) ≤ 0 (for example when Ψ(x) is constant), by
applying the Dulac - Bendixon theorem with multiplicative factor 1
(xyφ(x))
one
obtains that the presence of limit cycles is not possible. In fact:
Div(
1
xyφ(x)
(x′(x, y), y′(x, y))) =
αy′c(x)
y
− σ q(x)
xφ(x)y2
< 0 (3.13)
3.2 On immunotherapies
3.2.1 Therapy schedulings
A realistic anticancer therapy may be modeled with sufficient approximation
as constant (e.g. via a constant intravenous infusion) or periodic (e.g. the
agent is delivered each day as a bolus):
θ(t) = θm + Ω(t) ≥ 0, θ(t+ T ) = θ(t), θm =
1
T
∫ T
0
θ(t)dt (3.14)
For humans, typical periods ranges between 8 hours to 7 days [VVJ97, Edi03].
A particular case of periodic therapy is pulsed therapy, i.e. a therapy which
induces an instantaneous increase of the number of lymphocytes:
θ(t) = γ
+∞∑
n=0
δ(t− nT ) (3.15)
In the case of constant infusion therapy (CIT) (θ(t) = θm) by defining:
σ̂ := σ + θm, q̂(x) :=
σ + θm
σ̂
(3.16)
3.2.2 Continuous infusion therapy
All the considerations we have done the absence of therapy hold also in case
of CIT. In particular, for f(0) < +∞, the condition for the LAS of the
cancer-free equilibrium is:
σ + θm > σcr (3.17)
67
Because of the co-presence of other equilibria, the above criterion is not
global, i.e. the immunotherapy is not able to guarantee the disease eradi-
cation from whatever initial values (x(0), y(0)). However, observing that in
models in which Ψ(x) > 0:
ywiththerapyI (x) =
σq(x) + θm
Ψ(x)
> ynotherapyI (x) (3.18)
(e.g. in Stepanova’s model with low µ1) it happens that, roughly speaking,
the stable equilibrium size of the cancer becomes smaller and the unstable
equilibria greater, so that the basin of attraction of the unbounded solution
is reduced. When f(0) = +∞ the total elimination cannot be achieved by
immunotherapy alone. Furthermore, even the suboptimal target of reducing
the cancer to a microscopic size in many relevant cases cannot be achieved
for therapies of finite duration, however they may be long. In fact, let it be
Ψ(x) > 0 (aggressive tumor) and let there be a unique GAS macroscopic
equilibrium EMACRO. By applying a CIT with θ sufficiently high there is a
unique GAS microscopic equilibrium. However, when the therapy ceases θ
falls to zero and the cancer restarts growing macroscopically, since EMACRO
is again GAS. We note in brief that if the original equilibrium is microscopic
(e.g. micrometastasis) the effect of the therapy is simply to create another
and temporary microscopic equilibrium.
Let us suppose that there are three co-existing equilibria: Eomicro (LAS),
EoU (Unstable and through which a separatrix Σ
o passes) and EoMACRO (LAS).
Applying a CIT with θ > θ̃ there is an unique GAS microscopic equilibrium.
Thus at the end of the therapy (at t = tf ) depending on the position of
Pf = (x(tf ), y(tf )) relatively to Σ
o, we have that either (x(t), y(t))→ Emicro
or (x(t), y(t))→ EMACRO.
We note that θ acts a global bifurcation parameter, and we point out
that these behavior may be observed in case of bounded f(0) when therapy
is applied for an insufficient time.
3.2.3 Periodic Scheduling
In the case of periodic drug schedulings, there is a periodically varying cancer-
free solution CF ∗ = (0, z(t)), where z(t) is the asymptotic periodic solution
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of:
y′ = −Ψ(0)y + σ + θm + Ω(t) (3.19)
that, assuming Ω(t) =
∑+∞
n=1 CkCos(k(2π/T )t− ζn), can be rewritten as::
z(t) =
σ + θm
Ψ(0)
+
+∞∑
n=1
Ck√
Ψ2(0) + k2(2π
T
)2
Cos(k
2π
T
t− ζn − Arg(Ψ(0) + ik
2π
T
)).
(3.20)
Note that if T << 1/Ψ(0) there is a filtering effect and z(t) ≈ (σ+θm)/Ψ(0).
Two basic models of therapy may be:
•
θu(t) = A(1 + bcos(ωt)) (3.21)
which is rather unrealistic, but whose functional form is commonly
used to assess the effect of periodic forcing on nonlinear systems. The
asymptotic solution of (3.19) corresponding to (3.21) is given by:
zu(t) =
σ + A
Ψ(0)
+
Ab√
Ψ2(0) + ω2
Cos(ωt− Arg(Ψ(0) + iω))
• the more realistic function:
θr(t) =
G
1− Exp(−cT )
exp(−cMod(t, T )) , θm =
G
cT
, (3.22)
which represent a boli-based delivery. The ”shape” of θr(t) depends on
c and the corresponding asymptotic periodic solution of (3.19) is given
by:
zr(t) =
σ
Ψ(0)
+
G
Ψ(0)− c
X(
E−cMod(t,T )
1− E−cT
− E
−Ψ(0)Mod(t,T )
1− E−Ψ(0)T
)
In case of impulsive therapy, by solving the impulsive differential equation
y′ = −Ψ(0)y + σ, y(nT+) = y(nT−) + γ, n = 0, 1, . . . (3.23)
one obtains that:
z(t) =
σ
Ψ(0)
+
γ
1− exp(−Ψ(0)T )
Xexp
(
−Ψ(0)Mod(t, T )
)
. (3.24)
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Furthermore, it is easy to show that the condition σ + θm > σcr guarantees
the LAS of CF . In fact, since the variational equations around (0, z(t))
are: U ′ = (αf(0) − φ(0)z(t))U,W ′ = (σq′(0) − Ψ′(0)z(t))U − Ψ(0)W , we
obtain that αf(0) − φ(0) < z(t) >< 0 ⇒ U(t) → 0 ⇒ W (t) → 0, and
since < z(t) >= (σ + θm)/Ψ(0) we recover the LAS condition σ + θm > σcr.
Similarly, one may demonstrate the GAS condition: σ + θm > σ
∗.
3.3 Numerical simulations
I performed a set of simulations of the model proposed by Kuznetsov et al. in
(3.6), (3.7), choosing parameter values fitted from real data of chimeric mice.
• Considering a ”low aggressive tumor” I used the following parameters:
f(x) = 1.636(1 − 0.002x),φ(x) = 1, β(x) = 1.131x
20.19+x
σq(x) = 0.1181,
µ(x) = 0.00311x+0.3743 and ttrue = 9.9tadim days,(X, Y ) = 106(x, y)cells.
• Considering a ”more aggressive tumor” I used those parameters:
f(x) = 1.636(1 − 0.002x),φ(x) = 1, β(x) = 1.131x
20.19+x
σq(x) = 0.1181,
µ(x) = 10(0.00311x) + 0.3743 and ttrue = 9.9tadim days,(X, Y ) =
106(x, y)cells.
Note that the dynamic of tumors in mouse is faster than that of human
tumors, and that for periods of about 1 day or less (i.e. T < 0.101) it results
that ( 1
µ(0)
) ≥ T .
For the non-aggressive tumor σcr ≈ 0.612 and σ∗ ≈ 1.44 σ.
It clearly important to notice that in other kinds of anticancer therapies the
shape of the therapy may be critical in determining whether or not the cancer
will be eradicated. I found that:
In the absence of therapy non-aggressive tumor has two stable equilibria,
one slightly less than the carrying capacity and the other corresponding to a
small tumor. For the highly aggressive tumor there is one GAS equilibrium
slightly less than the carrying capacity (see phase portrait in Fig. 3.1).
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3.1.1 Non-Aggressive tumor 3.1.2 More-Aggressive tumor
Figure 3.1: On the left: Non-aggressive tumor, phase portrait of model ((3.6),
(3.7)) in the absence of therapy. There are two LAS equilibria. The nullcline
yC(x) is plotted in red, the nullcline yI(x) and its vertical asymptotes are
plotted in green. On the right: More-aggressive tumor, phase portrait of
model ((3.6),(3.7)) in the absence of therapy. There is one GAS equilibria
slightly less than the carrying capacity. The nullcline yC(x) is plotted in red,
the nullcline yI(x) is plotted in green.
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Chapter 4
Noise and noise-induced
transitions
One could say that in the course of its unfolding, life continuously chooses
stochastically among many, perhaps infinitely many, possible scenarios. In
one realization of the process, the scenario which will be followed cannot be
predicted with certainty. So, we can say that macroscopic world is far less
deterministic, i.e predictable in the classical sense, then we ever thought. In
fact, completely new aspects of randomness have come to light which call
for a profound reappraisal of the role and importance of random phenomena
in nature. The investigation of self-organization in non equilibrium systems
which are coupled to fluctuating environments has brought forth a great
impetus to reappraise the role of randomness. In fact, in a large class of phe-
nomena environmental randomness can, despite its apparently disorganizing
influence, induce a much richer variety of behaviors than that possible under
corresponding deterministic conditions. Astonishingly , an increase in envi-
ronmental variability can lead to a structuring of non linear systems which
has no deterministic analog. It is possible to extend the concept of phase
transition to the new class of non equilibrium transition phenomena which
are induced by environmental randomness. We can call them noise-induced
non equilibrium phase transitions or noise induced transitions (This class
is close to the classical equilibrium phase transition and the class of non
equilibrium phase transition). It must be observed that for noise-induced
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transitions the situation is not as neat as it is for classical equilibrium and
non equilibrium phase transition, it is far from unpredictable and lawless.
The notions an concepts, developed for classical transition phenomena and
essentially rooted in a deterministic conception of nature , can be extended
and adapted to deal with situations where noise plays an important role.
A theoretical investigation is thus made possible and more important, the
situation is accessible to experimental investigation.
4.1 Stochastic processes
Real environments vary randomly in the course of time. This can be modeled
by using a random variable to describe the state of the environment at each
instant of time. We thus obtain a family of random variables indexed by the
parameter time t. The fluctuations of the environment induce in their turn
random variations in the state of the system. Here again, we can describe
the temporal evolution of the system by a family of random variables that
at each instant of time represents the state of the system.
Definition: Random or stochastic process
A family of random variables indexed by the parameter time t is called a
random (or stochastic) process. More precisely, a set (Xt; t ∈ θ) of real valued
random variables, i.e Xt : (Ω,A, P )→ (R,B), is called a random process (or
random function) with the index set θ and state space <. Ω represents the
ensemble of elementary outcomes, A is the σ field (or σ algebra) of the events,
P is the probability measure, B is the Borel σ field. As far as notation is
concerned, stochastic processes will be denoted by Xt, whereas deterministic
time-dependent functions will be written as X(t).
4.1.1 Brownian motion
Brownian motion has played a central role in the theory of random phenom-
ena in physics as well in mathematics. It is the rapid, perpetual, highly
irregular motion of a small particle suspended in a fluid. The main features
of Brownian motion, as established by experiments in the last century are:
• smaller particles move more rapidly.
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• lowering the viscosity of the fluid also leads to more rapid motion.
• motion becomes more active when the fluid is heated.
• the motion is ceaseless and the trajectories are so irregular, their details
are so fine, that they seem to have no tangent, i.e. the velocity of
Brownian particle in undefined.
Quite a few explanations were proposed for this strange phenomenon before
the true case of this perpetual motion was understood and the first theoret-
ical treatment was given by Einstein. The chaotic motion of the suspended
particle is maintained by the collisions with the molecules of the surround-
ing medium. There is a mathematical model of Brownian motion which is
generally known as the Wiener process.
4.1.2 The Wiener Process
Definition: Brownian motion (or standard Wiener process)
A scalar standard Brownian motion, or standard Wiener process, over
[0, T ] is a random variable Wt that depends continuously on t ∈ [0, T ] and
satisfies the following three conditions:
1. W0 = 0 (with probability 1).
2. For 0 ≤ s < t ≤ T the random variable given by the increment Wt−Ws
is normally distributed with mean zero and variance t−s; equivalently,
Wt−Ws ∼
√
t− sN(0, 1), where N(0, 1) denotes a normally distributed
random variable with zero mean and unit variance.
3. For 0 ≤ s < t < u < v ≤ T the increments Wt −Ws and Wv −Wu are
independent.
The properties of the Wiener process, namely to be Gaussian distributed
and to have independent increments, reflect closely the characteristic fea-
tures of Brownian motion. The stochastic process Wt is thus a satisfactory
mathematical model of the latter. Indeed, the displacement of a Brownian
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particle is the sum of a very large number of independent infinitesimally
small displacements due to the collisions. Invoking the central limit theorem
we therefore expect the change in position of the Brownian particle to be
Gaussian distributed. Furthermore, the displacements occurring over non
overlapping time intervals should be stochastically independent, since they
are due to collisions which are independent of each other. The stationarity
of the displacements reflects the fact the fluid is in equilibrium.
The Wiener process itself is not a stationary process since probabilities
p(x, t + u) 6= p(x, t). The expectation value and the correlation function
are easily calculated to be:
E[Wt] = 0 (4.1)
E[(Wt)(Ws)] = min(t, s) (4.2)
The mean square displacements of a Brownian particle
E[W 2t ] = t (4.3)
increases only linearly in time. Thus the Wiener process is also not stationary
in the wide sense. Though the sample paths of the Wiener process are with
probability one continuous functions, the Wiener process is, as befits a model
of Brownian motion, quite ”irregular”. With probability one, the sample
functions are nowhere differentiable, i.e, the velocity of a Brownian particle
is undefined, and they have infinite length on any finite time interval.
4.1.3 The Ornstein-Uhlenbeck Process
If the Wiener process is used to model Brownian motion, i.e is chosen as
a stochastic process to represent the position of Brownian particle, then
the instantaneous velocity is not defined in this model. It is infinite, since
the sample paths of Wt are nowhere differentiable. This can be avoided by
considering the velocity of the Brownian particle instead as the main random
quantity as done by Uhlenbeck and Ornstein. This stochastic process is
therefore known as the Ornstein-Uhlenbeck process.
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4.2 Stochastic Models of Environmental Fluc-
tuations
Three main elements characterize stochastic processes: the nature of the state
variables, the index parameter set θ and the dependence relations among the
random variables Xt.
The parameter set θ is trivially in all cases the time axis. As to the state
space , we distinguish between continuously varying parameters and discrete
parameters: the former can be modeled by a process with Gaussian probabil-
ity law, the latter by a Poisson process. The motion of a Brownian particle
we have just seen is a basic example for Gaussian stochastic process.
We now turn our attention to the dependence relation between the random
variables making up the stochastic process used to model environmental fluc-
tuations. It was observed that in a broad class of applications a clear cut
separation of time scales exists, namely that the environmental state varies
much faster than the macroscopic state of the system. This led to consider
a stochastic process with extremely short memories and in a rather natural
way the notion of white noise, a completely random process with indepen-
dent values at every instant of time, arose. We shall now have a close look
at the passage from a real noise with a short memory to the idealization of
white noise with zero memory.
4.2.1 Correlation function and noise spectrum
As a first step towards a clear formulation of the way to model environmental
fluctuations we have to quantify the notion of rapid external noise. We look
for the characteristics defining the time scale of the system and that of the
environment.
The systems we shall deal with here are governed by a phenomenological
equation of the type:
Ẋ(t) = h(X(t)) + λg(X(t)) = fλ(X(t)). (4.4)
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We denote by τmacro the time that is typical for the macroscopic temporal
evolution of the system (we shall usually identify τmacro with the relaxation
time of the system towards a reference steady state X̄ found under the aver-
age environmental conditions). To be precise, X̄ is defined by:
h(X̄) + E[λt]g(X̄) = 0, (4.5)
and we determine τmacro via the linear stability analysis. This yields to
ω(X̄) = ∂Xfλ(X)|X=X̄ (4.6)
and hence the characteristic macroscopic time is the relaxation time of the
system
τmacro = |
1
ω(X̄)
| (4.7)
A measure of the rapidity of the random environmental fluctuations is the
correlation time τcor. It is, so to speak, the memory time of the stochastic
process and it is defined for stationary process as:
τcor =
1
C(0)
∫ ∞
0
C(τ)dτ (4.8)
The rationale of this definition is easily understood. The right hand side
is the area beneath the normalized correlation function C(τ) = E[δXtδXt+τ ]
E[δXt2
]
C(τ)  1 and C(0) = 1. Intuitively one would say that the process has
a long memory, if C(τ) or C̃(τ)) decreases only slowly, implying a large
area beneath C̃(τ). On the other hand, for a process with a short memory,
C(τ) or C̃(τ)) decreases rapidly, thus giving rise to small area beneath C̃(τ).
The normalized correlation function is used in order to be able to compare
processes with different values for the variance.
A rapidly fluctuating environment can be characterized by the property that
the correlation time τcor of the stochastic process λt is much smaller than the
typical macroscopic time τmacro of the system:
τcor  τmacro. (4.9)
An alternative way, different from the correlation function, to characterize the
dependence relation between the random variables Xt, is based on the fact,
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which we quote without proof, that any stationary process can be written
as a superposition of oscillations with frequency ν, with random amplitude
and phase. The so called frequency spectrum S(ν) is then a measure for the
mean square power with which an oscillation of frequency ν contributes to
the process Xt. S(ν) is just the Fourier transform of the correlation function
hence contains the same information on the process:
C(τ) =
∫
R
eiντS(ν)dν. (4.10)
Due to a well-known property of the Fourier transform, a narrow frequency
spectrum S(ν) corresponds to a slowly decreasing broad correlation function
C(τ). And vice versa, a broad frequency spectrum is associated with a rapidly
decreasing correlation function. This implies that rapid external fluctuations
τcor  τmacro having a narrow correlation function possess a broad frequency
spectrum with an effective band width νb defined as:
νb =
1
S(0)
∫ ∞
0
S(ν)dν (4.11)
which is very large compared to the typical frequency of the system:
νb  ω(X̄) (4.12)
Typically, the environments of natural systems fulfill this last condition. This
feature is easily understood: external noise can be expression of turbulent
or chaotic state, a defining property of which is a broad-band spectrum, or
the external parameter depends on a multitude of interfering environmental
factors, implying that a large number of harmonic modes are ” excited ” and
intervene in its temporary behavior. Therefore in a large class of applications,
the environmental fluctuations are very rapid in the sense described above.
4.2.2 The White-Noise Process
If τcor  τmacro, one is tempted to pass to the limit τcor = 0. The rationale
to adopt this idealization is the following: the memory of the environment is
extremely short compared to that of the system. It is therefore reasonable to
expect that any effects related to it are barely perceptible in the macroscopic
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system. Hence, no qualitative change in the macroscopic behavior should
occur if we set the non vanishing but extremely short correlations equal
to zero. This means that the environment can be adequately described by
a process with independent values at each instant of time, i.e., a so called
completely random process. Some circumspection, however, has to be exerted
in passing to the limit τcor = 0 because if we approach the limiting process,
having independent values, simply by letting the correlation time go to zero,
we shall not only neglect memory effects but at the same time get rid of any
effect of the environmental fluctuations. To see this, consider a Gaussian
process with an exponentially decreasing correlation function, O-U process.
The frequency spectrum of the O-U process is given by:
S(ν) =
1
2π
∫
<
e−iντC(τ)dτ =
1
2π
∫
<
e−iντ (σ2/2γ)e−γ|τ |dτ = (
σ2
2π
)(ν2 + γ2)−1
(4.13)
The correlation time of the O-U process is:
τcor = γ
−1 (4.14)
Hence the limiting τcor → 0 corresponds to γ → ∞. It is easily seen that
in this limit the mean square power with which oscillation of frequency ν
contribute to the O-U process Xt vanishes, i.e
limγ→∞S(ν) = 0, ν ∈ < (4.15)
This implies that a decrease in the correlation time τcor without changing
the other characteristics of the process leads eventually to a situation in
which the random variations have no impact at all on the system, simply
because in this limit the total input power S = 2
∫∞
0
S(ν)dν = σ
2
2γ
= C(0) is
spread uniformly over infinitely many frequencies. The limit τcor → 0 is too
simplistic. It implies more than just neglecting the memory of the noise, in
fact it is a noiseless limit.
If the external noise with a short memory is to be replaced by an equivalent
idealized noise with zero memory, then in the light of the above discussion
the appropriate limiting procedure is to couple the decrease in τcor with an
adequate increase in the strength of fluctuations. From (4.13) it follows that
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a finite limit is obtained, if concomitant with τcor → 0, σ2 → ∞ such that
σ2/γ2 is a constant and not the variance σ2/2γ. In the limit τcor → 0,
σ → ∞ such that σ2γ2 = const = σ̄2 the frequency spectrum of the O-U
process converges to
S(ν) =
σ̄2
2π
(4.16)
i.e completely flat spectrum. For its correlation function we obtain in this
limit
C(τ) = σ̄2δ(τ) (4.17)
Here δ(τ) denotes the Dirac delta function (zero everywhere except at τ = 0
where it is infinitely high such that
∫
< δ(τ)dτ = 1).
As is clear from the frequency spectrum and correlation function, a δ-correlated
process has a flat spectrum. This property is at the origin of the name White
noise for such processes; all frequencies are present with equal power as in
white light. The O-U process is a Gaussian process, a property which is
conserved in the limiting procedure. For this reason, the limiting process for
τcor → 0 of the O-U process is known as Gaussian white noise and is in the
following denoted σ̄ξt (where ξt is the standard Gaussian white noise with
E[ξt] = 0 and E[ξtξt+τ ] = δ(τ)).
Gaussian white noise is an extremely irregular process. It jumps widely
around; its realizations are nowhere continuous. Clearly there are other
kinds of white noise besides the Gaussian one; it is not difficult to character-
ize a white-noise process since its defining feature is that it is a completely
random process, i.e it has independent values at every instant of time, and
has infinite variance. In other words, any process whose correlation function
is proportional to a Dirac delta function qualifies as white noise.
It is easy to obtain all possible white noises. Consider a process Vt with
stationary independent increments, as for instance, the Wiener process Wt
or the Poisson process νt. Then the random variables (Vt+h − Vt)/h and
(Vs+h − Vs)/h are independent random variables for h sufficiently small and
t > s. This property would also be conserved in the limit h → 0 if it could
be properly defined. Thus is tempting to think of white noise as the time
derivative of a process with stationary independent increments; the Gaussian
white noise would be the time derivative of the Wiener process and differ-
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entiating the Poisson process would yield, in this spirit, the Poisson white
noise.
Hence, the important result is that there is a one to one relation between
white-noise processes and ordinary processes with white stationary indepen-
dent increments namely, ”white noise = (d/dt) (processes with stationary
independent increments)”. Since the latter class of processes is completely
known [I.I74], so is then the ensemble of possible white noises. Though Gaus-
sian white noise is so very irregular, it is extremely useful to model rapidly
fluctuating phenomena. Not surprisingly, in view of its properties, true white
noise of course does not occur in nature. However, as can be seen by their
spectra, lots of natural noises are white to a very good approximation.
4.2.3 Phenomenological modeling of macroscopic sys-
tems
These considerations put the final touch to the phenomenological modeling
of macroscopic systems, subjected to rapidly fluctuating environment. In the
idealization of δ-correlated external noise, the system is described by a SDE
of the form:
Ẋ = h(Xt) + λg(Xt) + σg(Xt)ξt = fλ(Xt) + σg(Xt)ξt (4.18)
where we have suppressed the bar over σ to denote the intensity of the Gaus-
sian white noise. What are the advantages of neglecting the small memory
effects of the environment?
Suppose the following situation: the state of the system at time t has been
determined accurately to be x. For the external parameter λt only its prob-
ability law is known, for instance that it is gaussian distributed. Consider
the situation under a more realistic than white noise, e.g. let ξt be an O-U
process. Then for a short time h into the future, the state of the system will
be given by
Xt+h = x+ fλ(x) + σg(x)ξth (4.19)
Of course, it would be convenient if the future stochastic evolution of the
system could be predicted solely on the basis of the information we possess
at the present time t on the state x of the system and on the environmental
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conditions as represented by the probability of ξt. In mathematical terms,
the probability that the system is in state y at some future time t+h should
depend only on the present state x and the stationary probability density
Ps(z) describing the environment, but not on the past history. Such a sit-
uation is the closest stochastic analog to the deterministic situation, where
X(t) in (4.4) is completely determined, once the initial condition X(0) is
given. This property is a verbal description of the defining feature of Markov
processes.
Definition: Markov chain
Let χ = (x1, ...., xn) be the set of a finite number of discrete states. The
stochastic process X = (Xt, t ∈ <+) is a continuous time Markov chain if it
satisfies the following Markov property
P (Xt = xj|Xs = xi) = P (Xt = xj|Xr1 = xi1 , ....Xrn = xin , Xs = xi) (4.20)
for 0 ≤ r1 ≤ .... ≤ rn < s < t and all xi1 ...xin , xi, xj ∈ χ.
Definition: Markov process
The stochastic process X = (Xt, t ∈ <+) is a (continuous time continuous
state) Markov process if it satisfies the following Markov property:
P (Xt ∈ B|Xs = x) = P (Xt ∈ B|Xr1 = x1, ....Xrn = xn, Xs = x) (4.21)
for all Borel subsets B ⊂ < , time instants 0 ≤ r1 ≤ .... ≤ rn ≤ s ≤ t and all
x1...xn, x for which the conditional probabilities are defined.
For fixed s,x and t the transition probability P (Xt ∈ B|Xs = x) is a proba-
bility measure on the sigma algebra B of Borel subsets of < such that
P (Xt ∈ B|Xs = x) =
∫
B
p(s, x; t, y)dy (4.22)
for all B ∈ B. The quantity p(s, x; t, .) is the transition density.
From the Markov property it follows that
p(s, x; t, y) =
∫ ∞
−∞
p(s, x; τ, z)p(τ, z; t, y)dz (4.23)
for all s ≤ τ ≤ t and x, y ∈ <. This equation is known as the Chapman
Kolmogorov equation.
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It’s important to say that the system can have the above property only
if the environment is indeed already completely characterized by its one-
dimensional density ps(z) and not, as is generally the case, by the infinite
hierarchy of its n-dimensional probability densities. The only class for which
this is true are the processes with independent values at every instant of
time, since for completely random processes
p(z1, t1; ...; zn, tn) = Π
n
i=1ps(zi). (4.24)
So, if the environment had a finite memory, the information of the past would
indeed improve our prediction capabilities of the feature stochastic evolution
of the system. These heuristic considerations suggest that the system is
Markovian if and only if the external fluctuations are white. The following
theorem holds: ”the process Xt, being a solution of (4.18) is Markovian, if
and only if the external noise ξt is white”. This result explains the impor-
tance and appeal of the white-noise idealization. If the system, coupled to
a fluctuating environment, can be described by a Markov process, then we
have the full arsenal of tools developed to deal with such stochastic processes
at our disposition.
4.3 Noise induced non-equilibrium phase tran-
sitions
We want now to describe a new class of non equilibrium phase transitions,
namely changes in the macroscopic behavior of non linear systems induced
by external noise. First of all it’s important the choice of systems:
• We shall consider systems spatially homogeneous.
• We shall consider macroscopically large systems and assume they have
reached the thermodynamic equilibrium.
• We shall consider systems which can be described by one intensive
variable (to have exact analytical results).
84
Then, the influence of the environment on the macroscopic properties of the
system is described on the level of the phenomenological equation via the
external parameters λ. If the system is coupled to a fluctuating environment,
then these parameters become in turn stochastic quantities. They can be
represented by stationary stochastic processes λt:
λt = λ+ σξt (4.25)
where λ represents the average state of the environment, ξt the fluctuations
around λ (ξt has zero mean value and intensity σ
2). Including it in the
phenomenological description we get the Stochastic differential equation:
Ẋ = fλ(t)(X(t)) = h(Xt) + λg(X(t)) + σξtg(X(t)) (4.26)
The models for environmental fluctuations can be chosen among the most
simple and basic classes of stochastic processes, Gaussian (for continuous
varying external parameters) and Poisson processes (for discrete external
parameters). Integrating the equation above we get:
Xt = X0 +
∫ t
0
fλ(Xs)ds+ σ
∫ t
0
g(Xs)ξsds (4.27)
Formulated in this manner, the question is now how to arrive at the consistent
definition of the stochastic integral
∫
g(Xs)ξsds which is the main source of
confusion. The problem is that though a sense can be given to this integral
and thus to the SDE (4.26), in spite of the extremely irregular nature of the
white noise, there is no unique way to define it, precisely because white noise
is so irregular. There are two different ways to define this integral, Ito and
Stratonovich, they give different results. Both definitions are based on the
heuristic relation that integration of Gaussian white noise yields Brownian
motion, which we shall denote by Wt. Therefore the above integral can be
written ∫
g(Xs)ξsds =
∫
g(Xs)dWs (4.28)
The integral on the right hand side is then defined , as in the case of an
ordinary integral, by the limit of the approximating sums∫
g(Ws)dWs = lim
∑
g(Wtj−1)(Wti −Wti−1) (4.29)
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in the Ito sense and in the Stratonovich sense∫
g(Ws)dWs = lim
∑
g(
Wti−1 +Wti
2
)(Wti −Wti−1). (4.30)
So, the only difference is the choice of the evaluation point. Ito chooses the
left-hand pointWti−1 in the partition of the time interval, whereas Stratonovich
opts for the middle point
(Wti−1+Wti )
2
. For an ordinary (deterministic) inte-
gral, ∫
U(X)dX = lim
∑
U(X̃i)(Xi −Xi−1), (4.31)
any evaluation point X̃i, as long as X̃i ∈ [Xi−1, Xi) can be chosen; the limit
is independent to it. Due to the extremely wild behavior of the Gaussian
noise, this is no longer true for the stochastic integral. The limit of the
approximating sums depends on the evaluation point; Ito and Stratonovich
yield different answers for the same integral:
Ito :
∫ t
0
WsdWs =
1
2
(W 2t −W 20 )− t2
Stratonovich:
∫ t
0
WsdWs =
(W 2t −W 20 )
2
Both the Ito and Stratonovich definitions are mathematically correct and
can serve as the basis for a consistent calculus.
Systems coupled to a rapidly fluctuating environment can be modeled by
Markov processes that are solutions of the stochastic differential equations.
The description of (4.26) can be based on:
Ito SDE: dXt = [h(Xt) + λg(Xt)]dt+ σg(Xt)dWt
Stratonovich SDE: dXt = [h(Xt) + λg(Xt)]dt+ σg(X) ◦ dWt
In those two cases, the transition probability density p(y, t|x) can be
found using the Fokker Plank equation:
Ito: ∂tp(y, t|x) = −∂yfλ(y)p(y, t|x) + σ
2
2
∂yyg
2(y)p(y, t|x)
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Stratonovich: ∂tp(y, t|x) = −∂y[fλ(y)+σ
2
2
g′(y)g(y)]p(y, t|x)+σ2
2
∂yyg
2(y)p(y, t|x)
4.3.1 Stationary solution of the Fokker-Plank equation
(FPE)
Since environment fluctuations can be modeled by a stationary random pro-
cess, we expect that in general a system subjected to external noise for suffi-
ciently long time will also settle down to stationary behavior. It means that,
on time goes to infinity, the system will attain a probability density ps(x)
whose shape does not change any more with time. Now, we shall determine
the stationary probability density ps(x) which characterizes the steady-state
behavior of the system under external white noise.
ps(x) is the stationary solution of the FPE which can be written in the form:
∂tp(x, t|x0, 0) + ∂xJ(x, t|x0, 0) = 0 (4.32)
where J(x, t|x0, 0) = f(x)p(x, t|x0, 0)− σ
2
2
∂xg
2(x)p(x, t|x0, 0). The stationary
FPE then reads: ∂xJs(x) = 0 and implies that the stationary probability
current is constant on the space [b1, b2]: Js(x) = const for x ∈ [b1, b2]. In the
stationary case, we have the probability current in the interior of the space
equal to the current across the boundaries which we call J:
J = Js(x) = Js(b1) = Js(b2) (4.33)
Now,
−f(x)ps(x) +
σ2
2
∂xg
2(x)ps(x) = −J (4.34)
which solving gives
ps(x) =
N
g2(x)
exp(
2
σ2
∫ x f(u)
g2(u)
du)− 2
σ2g2(x)
J
∫ x
exp(
2
σ2
∫ x
z
f(u)
g2(u)
du)dz
(4.35)
where N is determined by the normalization condition, J is the probability
current at the boundaries of the state space and depends on the nature of
the boundaries.
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It must be observed that, when the boundaries are natural (J = 0) [W.H84]
we get
ps(x) =
N
g2(x)
exp(
2
σ2
∫ x f(u)
g2(u)
du) (4.36)
To be a stationary probability density, has to be normalizable:
N−1 =
∫ b2
b1
1
g2(x)
exp(
2
σ2
∫ x f(u)
g2(u)
du) <∞ (4.37)
If one of the boundaries is attracting, regular or absorbing [W.H84], then
ps(x) = 0 for x ∈ (b1, b2), no regular stationary probability density exists.
For a diffusion process corresponding to Stratonovich SDE:
dXt = f(Xt)dt+ σg(X) ◦ dWt (4.38)
the stationary probability density for natural boundaries is:
ps(x) =
N
g(x)
exp(
2
σ2
∫ x f(u)
g2(u)
du) (4.39)
In general: The stationary behavior of a system describe by SDE
dXt = f(Xt)dt+ σg(X)dWt (4.40)
is given by:
ps(x) = Ng
−ν(x)exp(
2
σ2
∫ x f(u)
g2(u)
du) (4.41)
if J = 0, ν = 1 gives the Stratonovich interpretation , ν = 2 the Ito version.
It may happen that a SDE interpreted according to Ito admits a stationary
solution while interpreted according to Stratonovich it does not, or vice versa,
since the formula for ps(x) differ by a factor g
−1(x). If such a discrepancy
occurs, in general it signals that the model used to describe the system has
some dangerous or pathological features and one has to be doubly careful in
justifying the modeling procedure.
Theorem: If the diffusion process Xt is started with a probability density
that differs from the stationary one, it will approach the stationary density
as time tends to infinity limt→∞p(x, t) = ps(x).
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4.3.2 The neighborhood of deterministic behavior: ad-
ditive and small multiplicative noise
Consider a non linear macroscopic system which has been coupled with his
environment for a sufficiently long time to have settled down to a stationary
state. If the surroundings are varying, then the steady states of the systems
are zeros of the RHS of the deterministic equation:
Ẋ = h(X) + λg(X) (4.42)
Here we shall also suppose that the deterministic system is stable in the
sense that the solution X(t) does not blow up to infinity. To be precise,
∀X0 ∈ (b1, b2)∃C <∞, dependent on λ, such that
|X(t)| ≤ C ∀t (4.43)
if X0 = 0. This is fulfilled if a K > 0 exists such that:
h(x) + λg(x) < 0 ∀x > K (4.44)
and
h(x) + λg(x) > 0 ∀x < −K (4.45)
If X is a concentration like variable and has to be non negative, then RHS
of (4.42) has to obeys the following condition:
h(0) + λg(0) ≥ 0 ∀λ (4.46)
If both b1, b2 are finite, we require h(b1) + λg(b1) ≥ 0 and h(b2) + λg(b2) ≤ 0
for all λ. The solution of the first order, one-variable differential equation,
is a monotone function with respect to time since Ẋ takes one and only one
well-defined value for every x. Thus (4.43) implies that (4.42) admits only
one steady state.
If it admits more than one steady state , then stable and unstable ones
alternate. If there are two ore more stable stationary states, then the state
space divides in nonoverlapping regions, the ”basin of attraction” of the
various stable states. This is very easily seen if we write the phenomenological
equation in the form
Ẋ = −∂XVλ(X), where Vλ(x) = −
∫ x
[h(z) + λg(z)]dz (4.47)
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is called the potential of (4.42). The steady states are the extrema of the
potential Vλ(x) and the normal modes ω(X̄) of the linear stability analysis
are given by
ω(X̄) = ∂XXVλ(X̄) (4.48)
Hence, the stable steady states correspond to the minima of Vλ(x) and the
unstable steady states to the maxima.
We want now to analyze how the stationary behavior of a system is modified
in a fluctuating environment. In this case, the ”state” of the system is given
by a random variable.
The system is described by a degenerate random variable of the form
X(ω) = X̄i if X(0)(ω) ∈ A(X̄i) (4.49)
where A(X̄i) denotes the basin of attraction of the ith steady state. We
characterize this (degenerate) random variable by its probability law:
• In the deterministic case: the stationary probability density consist of
”delta peaks” centered on the steady state X̄i. The weight of the delta
peaks is given by the initial preparation of the system.
• In the stochastic case: external noise has a disorganizing influence. The
probability density has a maximum at the coordinate that corresponds
to the minimum of the potential and has a certain spread around it,
depending on the strength of the external noise. If there is more than
one minimum and if there is no effective upper bound on the external
fluctuations, then we expect a multimodal probability density with
peaks corresponding to the various minima of the potential.
A general picture emerges. The state of the system, i.e. the random variable,
is given by an interplay between the dynamics of the system and the external
fluctuations.
case 1: the intensity of the white noise is extremely small i.e σ  1
Defining
U(x) =
∫ x f(u)
g2(u)
du (4.50)
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we can write from (4.41) as
ps(x) = Nexp[
2
σ2
U(x̄m)]exp[
2
σ2
[U(x)− U(x̄m)−
νσ2
2
lng(x)]]. (4.51)
Here x̄m is the location of the highest maximum of U(x), which we suppose
to lie in the interior of the state space (b1, b2):
U(x) < U(x̄m) for x 6= x̄m.
If σ2 tends to zero and x 6= x̄m, the second factor becomes exponentially
small, so that the dominant contribution to the stationary probability density
comes from a neighborhood of the order of σ2 around the highest maximum
of U(x).
case 2: the external noise is additive: (g(x) = const = c)
U(x) = − 1
c2
Vλ(x) (4.52)
The highest maximum of U(x) and of the probability density ps(x) coincides
with the position of the deepest potential well for all σ2, x̄m = x̄; no shift
occurs.
case 3: the external noise is multiplicative:
U(x) 6= − 1
c2
Vλ(x) (4.53)
The highest maximum of U(x) is not necessarily the one with the deepest
potential well in the deterministic description.
Hence, the criterion of absolute stability for the deterministic steady states
depends explicitly on the nature of the random perturbations the system is
subjected to.
4.3.3 Transition phenomena in a fluctuating environ-
ment
We now analyze the stationary behavior of the macroscopic systems for ar-
bitrary noise intensities. What do we mean by a transition in a macroscopic
system coupled to a random environment and how do we detect such transi-
tions?
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Definition: Transition
A transition occurs precisely at that point in the parameter space, consisting
of the mean value of the external noise, its variance its correlation time etc..
where the functional form of the mapping from the sample space Ω into the
state space [b1, b2] changes qualitatively. This corresponds to a qualitative
change in the probability law characterizing the random variable.
In our case, this probability law is given by (4.41), the exact expression for
the stationary probability density of a system subjected to Gaussian white
noise. How can we detect such qualitative change?
The natural way is look at the deterministic situation for guidance and try
to extend the criteria used there to the stochastic case.
• In the deterministic case: a non equilibrium phase transition occur
when the potential Vλ(x) changes qualitatively. For instance, the num-
ber of local extrema changes. This fact has found its precise formulation
in catastrophe theory.
• In the stochastic case: is natural to consider the extrema of the station-
ary probability density ps(x) as indicators for a transitions. This choice
is not only the most direct extension of the deterministic concepts, but
also the most appropriate compared with other possibilities that come
to mind in the stochastic case as the moments of the distribution.
Example: Consider the time-dependent Landau equation, often used
to describe equilibrium critical phenomena:
dXt = (λXt −X3t )dt+ σdWt
In the deterministic case, σ = 0, a critical point occurs at λ = 0.
For λ negative the system has only one steady state, x̄ = 0, i.e the
potential Vλ(x) has only one minimum. For λ positive, x̄ = 0 becomes
a maximum of Vλ(x) and two minima develop at x̄ = ±λ
1
2 , i.e the
system now has to stable and one unstable steady states.
In the stochastic case, which corresponds to additive noise here, the
steady state behavior of the system is described by a random variable
whose probability law is given by
ps(x) = Nexp[−Vλ(x)/σ2].
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It is obvious that also in the stochastic case a qualitative change in the
steady state occurs at λ = 0. This transition is accurately reflected by
the behavior of the extrema of ps(x). If however the moment are used,
no transition phenomenon is detected. Clearly, it is not the mean value
that corresponds to the macroscopic states or phases of the system,
but the maxima of ps(x). This example confirms that the most direct
extension of the deterministic concepts as presented above is also the
most appropriate. A qualitative change in steady-state behavior is
unambiguously reflected in the extrema of the probability density. (The
only exception is the transition from a degenerate to a genuine random
variable. Here the variance is the best indicator.)
Since a transition occurs if the steady states of the system as given by the
random variable changes qualitatively, the extrema of the stationary proba-
bility density are merely a practical way to monitor such a qualitative change.
The number and position of the extrema of ps(x) in the stochastic case and
Vλ(x) in the deterministic case are the most distinguishing features of the
steady state behavior of the system.
In summary:
1. A transition occurs when the functional form of the random variable
describing the steady state of the system changes qualitatively.
2. This qualitative change is most directly reflected by the extrema of the
stationary probability law, except if the transition is due to a change
in the nature of boundary.
3. The physical significance of the extrema, apart from being the most ap-
propriate indicator of transition, is their correspondence to the macro-
scopic phases of the system. The extrema are the order parameter of
the transition.
The extrema of ps(x) are easily found from:
[h(xm) + λg(xm)]− ν
σ2
2
g(xm)g
′(xm) = 0 (4.54)
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basic equation for an analysis of the influence of rapid external noise on the
steady state behavior of macroscopic non-linear systems.
The basic equation (4.54) contains two terms. The one in brackets, set equal
to zero, corresponds to the equation for the deterministic steady states (4.42).
The second term describes the influence of external noise. We have again to
distinguish between two cases:
1. Additive noise (g(x) = 1): the influence of the environment fluctu-
ations does not depend on the state of the system. Consequently, the
extrema of ps(x) always coincide with the deterministic steady states,
independent of the intensity of the external white noise. Hence, addi-
tive external white noise does not modify qualitatively the stationary
behavior of one-variable systems.
2. Multiplicative noise (g(x) 6= 1): the effect of the environment fluc-
tuations does depend on the state of the system. If σ2 is sufficiently
small, then the roots of (4.54) do not differ in number and position from
the deterministic steady states. The external noise is not sufficiently
strong to change the potential qualitatively. If, however, the intensity
σ2 of the noise increases, then we come to a point where the second
term in (4.54) can no longer be neglected. In fact, if σ2 is sufficiently
large, the extrema of ps(x) can be essentially different in number and
position from the deterministic steady state, provided g(x) is nonlinear
in a suitable way f(x) = h(x) + λg(x) is a polynomial of degree n and
g′(x)g(x) a polynomial of degree m grater than n. When σ2 crosses
a certain threshold value the shape of ps(x), i.e the random variable
describing the stationary behavior of the system, can change drasti-
cally; a transition occurs. In addition to the disorganizing effect, which
it shares with the additive noise, multiplicative noise can create new
states, it can induce new non-equilibrium phase transitions which are
no expected from the usual phenomenological descriptions. These are
simply called noise-induced-transitions.
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4.3.4 Time dependent behavior of Fokker-Planck Equa-
tions
The preceding sections dealt with the stationary behavior of non linear sys-
tems coupled to a fluctuating environment. Sometimes it can be more in-
teresting to observe the transient behavior of such systems instead of the
stationary one. This problem is considerably harder than the analysis of sta-
tionary behavior and in general no explicit formula for the time dependent
solution of the FPE exists, even for one variable systems, in contrast with
the stationary solution.
The exact time-dependent solution of a SDE can be easily obtained only if the
drift and diffusion coefficients are linear functions. It is thus worthwhile for
a study of transient behavior to determine those non linear SDE’s which can
be transformed into a linear SDE by a bijective change of variable because
, for some systems belonging to this class, it is possible to derive the exact
time-dependent solution of the corresponding FPE in an explicit manner.
4.4 Numerical simulation of SDE:
Eulero-Maruyama method
In my thesis we will work with some SDEs. There are different methods
to solve SDEs analytically but we will not see these here. Instead, I will
now explain how to apply a simple numerical method to SDE: the Eulero-
Maruyama method which is the one I used in my numerical simulations.
A scalar, autonomous SDE can be written in integral form as
Xt = X0 +
∫ t
0
f(Xs)ds+
∫ t
0
g(Xs)dWs, 0 ≤ t ≤ T. (4.55)
Here, f and g are scalar functions and the initial condition X0 is a random
variable. The second integral on the right-hand side of (4.55) is to be taken
with respect to Brownian motion, and we assume that the Ito version is
used. The solution Xt is a random variable for each t. We do not attempt
to explain further what it means for Xt to be a solution to (4.55) instead
we define a numerical method for solving it, and we may then regard the
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solution Xt as the random variable that arises when we take the zero step
size limit in the numerical method.
It is usual to rewrite (4.55) in differential equation form as
dXt = f(Xt)dt+ g(Xt)dWt, X(0) = X0, 0 ≤ t ≤ T. (4.56)
This is nothing more than a compact way of saying that Xt solves (4.55). To
keep with convention, we will emphasize the SDE form (4.56) rather than
the integral form (4.55). (Note that we are not allowed to write dWt
dt
, since
Brownian motion is nowhere differentiable with probability 1.)
If g = 0 and X0 is constant, then the problem becomes deterministic, and
(4.56) reduces to the ordinary differential equation dXt
dt
= f(Xt), with X(0) =
X0.
To apply a numerical method to (4.56) over [0, T ], we first discretize the
interval. Let ∆t = T/L for some positive integer L, and τj = j∆t . Our
numerical approximation will be denoted Xj.
The Eulero Maruyama (EM) method takes the form:
Xj = Xj−1 + f(Xj−1)∆t+ g(Xj−1)(W (τj)−W (τj−1)), j = 1, 2, ..., L (4.57)
To understand where (4.57) comes from, notice from the integral form (4.55)
that
X(τj) = X(τj−1) +
∫ τj
τj−1
f(Xs)ds+
∫ τj
τj−1
g(Xs)dWs. (4.58)
Each of the three terms on the right-hand side of (4.57) approximates the
corresponding term on the right-hand side of (4.58). We also note that in the
deterministic case (g = 0 and X0 constant), (4.57) reduces to Eulero method.
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Chapter 5
Bounded noises
Traditionally, stochastic dynamical systems used in the physical sciences have
involved Gaussian noise. In recent times, however, it has been recognized
that the assumption of Gaussianity is not appropriate in some cases. The
Gaussian noise is unbounded, i.e., there exists a positive chance of having very
large values. Strictly speaking, this fact contradicts the very nature of a real
physical quantity which is always bounded. Studies of dynamical systems
with non-Gaussian continuous noise are much more complicated,especially
analytically. Although the literature devoted to the study of bounded noises
is far more limited than that concerning the Gaussian noise, in recent years
a number of interesting works have appeared [TW01, BC05].
Since the noise-induced transitions are dependent on the kind of density of
noise adopted [Fue07], we will now consider two different kind of ”Bounded
Noises”. The first is derived by applying a bounded function to a Wiener
process, the second through an Ito Stochastic differential equation nonlinear
in the diffusion term.
The first bounded noise we consider is the so called sine-Wiener noise [BC05]
given by
ν(t) = Bsen(
√
2
τcorr
W (t)) (5.1)
W ′ = ξ(t) (5.2)
where B is a constant, τcorr is the correlation time, ξ(t) is a white noise.
The sine-Wiener noise, as it is easy to verify, is such that < ν(t) >= 0
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,< ν2(t) >= B2/2 and
< ν(t)ν(t+ z) >=
B2
2
exp
(
−z
τ
)(
1− exp
(
−4 t
τ
))
,
where z ≥ 0.
The second is the Cai-Lin-Suzuki family of noises [CS05, CK04], which is
derived by a Langevin equation of the form:
ν ′(t) = −ην +D(ν)ζ(t), (5.3)
D(ν) ≥ 0 is a function such that D(|B|) = 0, and ζ(t) is a gaussian noise
with zero mean and unitary variance. We shall further assume that D(ν) is
a symmetric function.
As a consequence, the noise ν is then non-gaussian with zero mean, autocor-
relation time τ = 1/η and it satisfies the following bounds: −B < ν(t) < B.
In the particular case [CS05] where
D(ν) =
√
η
δ + 1
(B2 − ν2)
The stationary density of ν is:
Pst(ν) = N
(
1− ν
2
B2
)δ
+
where N is a normalization constant. Note that the density vanishes for
ν ≤ −B and ν ≥ B.
Cai Noise we consider is given by:
ν(t) = −1
τ
νdt+
1
τ
A(B2 − ν2)δdW (t) (5.4)
ν(0) = ν0 (5.5)
where τ describes noise’s correlation time, B noise’s amplitude, A, δ are pa-
rameters, dW (t) is a Wiener process.
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5.1.1 Sine Wiener noise 5.1.2 Cai noise
Figure 5.1: Bounded Sine Wiener noise (left figure) and bounded Cai noise
(right figure),with amplitude B = 1 and correlation time τ = 0.1.
5.2.1 Sine Wiener noise 5.2.2 Cai noise
Figure 5.2: Bounded Sine Wiener noise (left figure) and bounded Cai noise
(right figure),with amplitude B = 1 and correlation time τ = 1.
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Chapter 6
Bounded-noise-induced
transitions in a tumor-immune
system interplay
The objective of my simulations is to investigate the phenomenon of evasion
of tumor cells from immune control at a temporal mesoscale. Of course in
the very short term if either the tumor is lowly immunogenic or the level of
IS is per se slow (i.e because of immunodeficiency [CJ01]) it is obvious that
the transformed cells can easily and in short time evade control.
Over the long temporal range not only those slow evolutionary processes but
also the IS degradation due to natural senescence [V.A01] can explain long-
term evasions. However, middle term evasions are presumably representative
of the vast majority of case of immune surveillance failure.
An important factor that has been extensively investigated is the influence
of the fluctuations in the proliferation rates of a tumor [W.H84] [W.H77]
[A.d07]. Those fluctuations, however, play a dual role since they can also
trigger the elimination of the neoplasm.
Given the complexity and multistability of the T-IS interplay, we think that
a natural approach is to investigate the role of statistical fluctuations of im-
mune levels that might trigger noise-induced transitions. Moreover , from
modeling point of view, the extreme intricacy of the interactions between
tumor cells and immune effectors further justifies the inclusion of noise on a
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deterministic model of T-IS interplay in order to take into account a plethora
of relevant phenomena such as the variable strength of the neoantigens in
stimulating the immune response, the expression or absence of expression of
molecules needed for T cell activation, the dynamics of Treg cells that gen-
erate a state of tolerance to cancer.
In our simulations we have considered the tumor-immune system model al-
ready seen in chapter 3 introducing two different kind of ”Bounded Noises”:
Sine Wiener and Cai noise, with parameters values describing more aggres-
sive tumor.
A point to be stressed is that the classical theory of noise induced transitions
[W.H84] is an asymptotic theory that refers to the study of the qualitative
changes in stationary probability densities: Pst(x) = limt→∞P (x, t), where x
stands, in biological applications of this theory, for some biological property
such as the size of a cellular population, or the viral load or the average activ-
ity. Here, of course, we shall assume that x denotes the tumor size. However,
whatever asymptotic study might be, if the velocity of convergence of the
stationary density is slow,it is in contradiction with the basic fact that living
beings have a finite lifespan. Thus the lifespan of the host organisms must
be a natural limit to our numerical investigations, which makes the velocity
of convergence to Pst(x) an essential parameter. If this velocity is slow and
the attractor is practically reached in times that are excessively greater than
the average lifespan of the organisms in study, one has to investigate the
possible qualitative changes of P (x, t) during its transitory, namely at some
given realistic times. For this reason we focused here on transitory analysis
of P (x, t). Indeed, noise has been introduced on various parameters observ-
ing the probability density at time T = 100 corresponding , in dimensional
time unity, to 3 years about, both in case of Sine Wiener and Cai noise per-
turbations. It must be observed that all simulations have been done using
Matlab 7.0.4.
Recall: Kuznetsov model for the interaction between a population of tumor
cells and IS cells is given by the equations:
x′ = xα(1− bx)− φyx (6.1)
y′ =
βx
η + x
y − (µ0 + µ1x)y + σ (6.2)
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where x describes the number of tumor cells, y the number of IS effectors, α,
b, φ, β, η, µ0, µ1, σ are parameters.
6.1 Perturbation on parameter φ
I performed some simulations of the new system, obtained from (6.1), (6.2)
simply adding noise ν to the parameter φ, in both form of Sine Wiener and
Cai:
x′ = xα(1− bx)− (φ+ ν)yx (6.3)
y′ =
βx
η + x
y − (µ0 + µ1x)y + σ (6.4)
Before introducing noise, I did some simulations of the deterministic model
for parameters values fitted from real data of chimeric mice, aggressive tumor:
α = 1.636, b = 0.002, φ = 1, β = 1.131, η = 20.19, µ1 = 10 ∗ (0.00311),
µ0 = 0.3743,σ = 0.1181.
Varying φ values I found φtangent and φeradication which describe, respectively,
φ values that makes x nullcline tangent to y nullcline and x nullcline go to
zero. These values are given by: φtangent = 4.108 and φeradication = 49.269(see
figures 6.1.1, 6.1.2).
Now Choosing φ = 4.2, close to φtangent, so that the equilibrium point
may be quite metastable, I performed a series of some simulations.
6.1.1 φtangent = 4.108 6.1.2 φeradication = 49.269
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The following tables and figures show the results obtained by varying the
amplitude of the noise (B) and its correlation time (τ):
SW noise:
Amplitude (B) Correlation time (τ) Comments
0.01 0.1 //*
0.01 0.5 //
0.01 1 //
0.01 6 //
0.08 0.1 Evident oscillations
0.08 0.5 Evident oscillations
0.08 1 Evident oscillations
0.08 3 Evident oscillations
0.095 0.1 Evident oscillations
0.095 0.8 Evident oscillations
0.095 3 Evident oscillations
0.1 1 Evident oscillations
0.2 1 Evident oscillations
0.2 2 Evident oscillations
0.2 3 Evident oscillations
0.2 8 Evident oscillations
0.5 1 Evident oscillations
0.8 0.1 Evident oscillations
0.8 1 Evident oscillations
1 1 Evident begins
1.2 1 Evasion
1.4 1 Evasion
1.6 1 Evasion
* No relevant observations.
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Cai noise:
Amplitude (B) Correlation time (τ) Comments
0.01 0.1 //
0.01 0.5 //
0.01 1 //
0.01 6 //
0.08 0.1 Evident oscillations
0.08 0.5 Evident oscillations
0.08 1 Evident oscillations
0.08 3 Evident oscillations
0.095 0.1 Evident oscillations
0.095 0.8 Evident oscillations
0.095 3 Evident oscillations
0.1 1 Evident oscillations
0.2 1 Evident oscillations
0.2 2 Evident oscillations
0.2 3 Evident oscillations
0.2 8 Evident oscillations
0.5 1 Evident oscillations
0.8 0,1 Evident oscillations
0.8 1 Evident oscillations
1 1 Evasion begins
1.2 1 Evasion begins
1.4 1 Evasion
1.6 1 Evasion
Observations:
Introducing a Sine Wiener noise, for some values of amplitude and correlation
time, I can notice a clear evasion from the point of microscopic equilibrium
to the macroscopic one as it is evident in the figures (6.3.1) (6.4.1) (6.5.1)
(6.6.1) (6.7.1) (6.8.1). Introducing a Cai noise, as well, for some values of
amplitude and correlation time, evasion is clear. See figures (6.5.2), (6.6.2)
(6.7.2) (6.8.2).
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Perturbation on parameter φ
6.1.3 Sine Wiener noise 6.1.4 Cai noise
Figure 6.1: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 1 and correlation time τ = 1, added on parameter φ. Starting
values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.2.1 Sine Wiener noise 6.2.2 Cai noise
Figure 6.2: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 1 and correlation time τ = 1, added on parameter φ. Starting
values are (x, y) = (0.1, 2).
106
6.3.1 Sine Wiener noise 6.3.2 Cai noise
Figure 6.3: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 1.2 and correlation time τ = 1, added on parameter φ. Starting
values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.4.1 Sine Wiener noise 6.4.2 Cai noise
Figure 6.4: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 1.2 and correlation time τ = 1, added on parameter φ.
Starting values are (x, y) = (0.1, 2).
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6.5.1 Sine Wiener noise 6.5.2 Cai noise
Figure 6.5: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 1.4 and correlation time τ = 1, added on parameter φ. Starting
values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.6.1 Sine Wiener noise 6.6.2 Cai noise
Figure 6.6: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 1.4 and correlation time τ = 1, added on parameter φ.
Starting values are (x, y) = (0.1, 2).
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6.7.1 Sine Wiener noise 6.7.2 Cai noise
Figure 6.7: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 1.6 and correlation time τ = 1, added on parameter φ. Starting
values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.8.1 Sine Wiener noise 6.8.2 Cai noise
Figure 6.8: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 1.6 and correlation time τ = 1, added on parameter φ.
Starting values are (x, y) = (0.1, 2).
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6.2 Perturbation on parameter β
I performed some simulations of the new system obtained from (6.1), (6.2)
simply adding noise ν to the parameter β, in both form of Sine Wiener and
Cai:
x′ = xα(1− bx)− φyx (6.5)
y′ =
(β + ν)x
η + x
y − (µ0 + µ1x)y + σ (6.6)
The following tables show the results obtained by varying the amplitude
of the noise (B) and its correlation time (τ):
SW noise:
Amplitude (B) Correlation time (τ) Comments
1 1 //
1.6 1 //
2 1 //
2 1.2 //
2 2 //
2.5 1 //
2.5 1.2 //
2.5 2 //
3 1 //
3 1.5 //
3 3 //
4 1.5 //
4 2 //
5 2 //
10 3 //
10 8 Evident oscillations
10 10 Evident oscillations
15 3 Evident oscillations
20 3 Evident oscillations
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Cai noise:
Amplitude (B) Correlation time (τ) Comments
1 1 //
1.6 1 //
2 1 //
2 1.2 //
2 2 //
2.5 1 //
2.5 1.2 //
2.5 2 //
3 1 //
3 1.5 //
3 3 //
4 1.5 //
4 2 //
5 2 //
10 3 //
10 8 Evident oscillations
10 10 Evident oscillations
15 3 Evident oscillations
20 3 Evident oscillations
Observation: Introducing an additive SW / Cai noise to the parameter
β there are no relevant changes in the model behavior.
6.3 Perturbation on parameter η
I performed some simulations of the new system obtained from (6.1), (6.2)
simply adding noise ν to the parameter η, in both form of Sine Wiener and
Cai:
x′ = xα(1− bx)− φyx (6.7)
y′ =
βx
(η + ν) + x
y − (µ0 + µ1x)y + σ (6.8)
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The following tables show the results obtained by varying the amplitude
of the noise (B) and its correlation time (τ):
SW noise:
Amplitude (B) Correlation time (τ) Comments
1 1 //
1 2 //
1 5 //
1 10 //
2 1 //
2 2 //
2 5 //
2 10 //
5 1 //
5 2 //
5 5 //
5 10 //
10 1 //
10 2 //
10 5 //
10 10 Evident oscillations
20 5 Evident oscillations
20 10 Evident oscillations
30 5 Evident oscillations
30 10 Evident oscillations
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Cai noise:
Amplitude (B) Correlation time (τ) Comments
1 1 //
1 2 //
1 5 //
1 10 //
2 1 //
2 2 //
2 5 //
2 10 //
5 1 //
5 2 //
5 5 //
5 10 //
10 1 //
10 2 //
10 5 Evident oscillations
10 10 Evident oscillations
20 5 Evident oscillations
20 10 Evident oscillations
30 5 Evident oscillations
30 10 Evident oscillations
Observation: Introducing an additive SW / Cai noise to the parameter
η there are no relevant changes in the model behavior.
6.4 Perturbation on parameter σ
I performed some simulations of the new system obtained from (6.1), (6.2)
simply adding noise ν to the parameter σ, in both form of Sine Wiener and
Cai:
x′ = xα(1− bx)− φyx (6.9)
y′ =
βx
η + x
y − (µ0 + µ1x)y + (σ + ν) (6.10)
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The following tables and figures show the results obtained by varying the
amplitude of the noise (B) and its correlation time (τ):
SW noise:
Amplitude (B) Correlation time (τ) Comments
0.01 0.1 //
0.01 0.5 //
0.03 0.5 //
0.03 0.8 Evasion begins
0.04 0.2 Evasion begins
0.04 0.4 Evasion
0.05 0.2 Evasion
0.05 0.5 Evasion
0.08 0.1 Evasion
0.08 0.5 Evasion
0.1 0.1 Evasion
0.1 0.5 Evasion
0.1 1 Evasion
0.11 0.1 Evasion
0.118 0.1 Evasion
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Cai noise:
Amplitude (B) Correlation time (τ) Comments
0.01 0.1 //
0.01 0.5 //
0.03 0.5 //
0.03 0.8 //
0.04 0.2 //
0.04 0.4 //
0.05 0.2 //
0.05 0.5 //
0.08 0.1 //
0.08 0.5 //
0.1 0.1 //
0.1 0.5 //
0.1 1 //
0.11 0.1 //
0.118 0.1 //
Observation: Introducing a Sine Wiener noise, for some values of am-
plitude and correlation time, I can notice a clear evasion from the point of
microscopic equilibrium to the macroscopic one as it is evident in the figures
(6.13.1) (6.14.1) (6.15.1) (6.16.1) (6.17.1) (6.18.1) (6.19.1) (6.20.1) (6.21.1)
(6.22.1). Introducing a Cai noise, instead, there are no relevant changes in
model behavior.
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Perturbation on parameter σ
6.9.1 Sine Wiener noise 6.9.2 Cai noise
Figure 6.9: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.03 and correlation time τ = 0.8, added on parameter σ. Start-
ing values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.10.1 Sine Wiener noise 6.10.2 Cai noise
Figure 6.10: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.03 and correlation time τ = 0.8, added on parameter
σ.Starting values are (x, y) = (0.1, 2).
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6.11.1 Sine Wiener noise 6.11.2 Cai noise
Figure 6.11: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.04 and correlation time τ = 0.2, added on parameter σ. Start-
ing values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.12.1 Sine Wiener noise 6.12.2 Cai noise
Figure 6.12: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.04 and correlation time τ = 0.2, added on parameter
σ.Starting values are (x, y) = (0.1, 2).
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6.13.1 Sine Wiener noise 6.13.2 Cai noise
Figure 6.13: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.04 and correlation time τ = 0.4, added on parameter σ. Start-
ing values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.14.1 Sine Wiener noise 6.14.2 Cai noise
Figure 6.14: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.04 and correlation time τ = 0.4, added on parameter
σ.Starting values are (x, y) = (0.1, 2).
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6.15.1 Sine Wiener noise 6.15.2 Cai noise
Figure 6.15: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitudeB = 0.1 and correlation time τ = 0.1, added on parameter σ. Starting
values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.16.1 Sine Wiener noise 6.16.2 Cai noise
Figure 6.16: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.1 and correlation time τ = 0.1, added on parameter σ.Starting
values are (x, y) = (0.1, 2).
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6.17.1 Sine Wiener noise 6.17.2 Cai noise
Figure 6.17: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.1 and correlation time τ = 1, added on parameter σ. Starting
values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.18.1 Sine Wiener noise 6.18.2 Cai noise
Figure 6.18: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.1 and correlation time τ = 1, added on parameter σ.Starting
values are (x, y) = (0.1, 2).
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6.19.1 Sine Wiener noise 6.19.2 Cai noise
Figure 6.19: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.11 and correlation time τ = 0.1, added on parameter σ. Start-
ing values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.20.1 Sine Wiener noise 6.20.2 Cai noise
Figure 6.20: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.11 and correlation time τ = 0.1, added on parameter σ.
Starting values are (x, y) = (0.1, 2).
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6.21.1 Sine Wiener noise 6.21.2 Cai noise
Figure 6.21: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitudeB = 0.118 and correlation time τ = 0.1, added on parameter σ. Start-
ing values are those of microscopic equilibrium point (x, y) = (4.83, 0.38).
6.22.1 Sine Wiener noise 6.22.2 Cai noise
Figure 6.22: Xfinal probability density over 5000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.118 and correlation time τ = 0.1, added on parameter
σ.Starting values are (x, y) = (0.1, 2).
122
6.5 Other simulations
Clearly, the noise can be inserted in many different ways within the model
considered.
Including a multiplicative factor (1+ν) to the parameter b we get the system:
x′ = xα(1− b(1 + ν)x)− φyx (6.11)
y′ =
βx
η + x
y − (µ0 + µ1x)y + σ (6.12)
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The following tables show the results obtained by varying the amplitude
of the noise (B) and its correlation time (τ):
SW noise:
Amplitude (B) Correlation time (τ) Comments
0.02 0.01 //
0.05 0.01 //
0.05 0.1 //
0.05 1 //
0.08 0.01 //
0.08 0.1 //
0.08 1 //
0.1 0.01 //
0.1 0.1 //
0.1 1 //
0.3 0.05 //
0.3 0.5 //
0.3 2 //
0.5 0.05 //
0.5 0.3 //
0.5 1 //
0.8 0.05 //
0.8 0.5 //
0.8 1 //
1 0.02 //
1 0.3 //
1 1 //
3 0.2 //
3 1 //
3 3 //
5 1 //
5 5 Evident oscillations
10 5 Evident oscillations
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Cai noise:
Amplitude (B) Correlation time (τ) Comments
0.02 0.01 //
0.05 0.01 //
0.05 0.1 //
0.05 1 //
0.08 0.01 //
0.08 0.1 //
0.08 1 //
0.1 0.01 //
0.1 0.1 //
0.1 1 //
0.3 0.05 //
0.3 0.5 //
0.3 2 //
0.5 0.05 //
0.5 0.3 //
0.5 1 //
0.8 0.05 //
0.8 0.5 //
0.8 1 //
1 0.02 //
1 0.3 //
1 1 //
3 0.2 //
3 1 //
3 3 Evident oscillations
5 1 Evident oscillations
5 5 Evident oscillations
10 5 Evident oscillations
Observation: There are no relevant changes in the model behavior.
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Including a multiplicative factor (1 + ν) to x we get the system:
x′ = xα(1− bx)− φyx (6.13)
y′ =
βx
η + x(1 + ν)
y − (µ0 + µ1x)y + σ (6.14)
The following tables show the results obtained by varying the amplitude
of the noise (B) and its correlation time (τ):
SW noise:
Amplitude (B) Correlation time (τ) Comments
0.01 0.01 //
0.01 0.1 //
0.05 0.1 //
0.05 1 //
0.08 1 //
0.08 3 //
0.1 1 //
0.1 3 //
0.5 1 //
0.5 5 //
1 0.1 //
1 1 //
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Cai noise:
Amplitude (B) Correlation time (τ) Comments
0.01 0.01 //
0.01 0.1 //
0.05 0.1 //
0.05 1 //
0.08 1 //
0.08 3 //
0.1 1 //
0.1 3 //
0.5 1 //
0.5 5 //
1 0.1 //
1 1 //
Observation: There are no relevant changes in the model behavior.
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6.6 Conclusions
As we can see from the results, the statistical fluctuations does not make the
tumor evade in all cases.
In the case of perturbations on the parameter φ , for B = 1.2, 1.4, 1.6 and
τ = 1 there is transition to bimodality with a considerable probability of
tumor explosion in both cases of SW and Cai noise. We recall that the bi-
ological meaning of this parameter is the rate of killing tumor cells by the
immune system effectors.
The introduction of perturbations on parameter σ shows a behavior that
depends on the kind of noise, since there is a remarkable difference between
the responses to SW and Cai noises. In the case of SW perturbations, we
observed transitions to bimodality with a considerable probability of tumor
explosion for noise amplitude and correlation time values: B = 0.03 ,τ = 0.8
; B = 0.04, τ = 0.2, 0.4 ; B = 0.05, τ = 0.2, 0.5 ; B = 0.08, τ = 0.1, 0.5 ;
B = 0.1, τ = 0.1, 0.5 ; B = 0.11, τ = 0.1 ; B = 0.118, τ = 0.1. Using Cai
noise, on the contrary, there are not relevant changes in model behavior. We
recall that the biological meaning of the parameter σ is the local influx of
immune system effectors.
Clearly, transitions depend on the noise model adopted. These observation,
confirming the biological intuition, suggest that SW fluctuations easily in-
duce immunoevasion while Cai fluctuations are generally filtered out or have
small effects.
In the case of perturbations on parameter β, η and other simulations there
are not relevant changes on model behavior.
In conclusion, our results seem to show that these perturbations may con-
tribute to triggering the tumor escape but-generally speaking-not so easy.
We showed that limiting the analysis at finite significant time (T=100), the
transition to larger values is not reached if the oscillation B of the noise is
too small or if the autocorrelation time τ is small.
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Chapter 7
Non-clonal resistance to
chemotherapy induced by its
stochastical fluctuations
We have seen in the previous chapter that, introducing a bounded noise-
band stochastic perturbation in a model of tumor-immune system interplay
may dramatically modify the behavior of its solutions. The above mentioned
analysis was in absence of the delivery of therapies, and was valid for highly
to moderately immunogenic tumors, which are able to trigger the action of
the immune system. Here we study a quite opposite case: the introduc-
tion of bounded perturbation in a simple but realistic novel mathematical
model of tumor growth in presence of the delivering of a constant continuous
chemotherapy.
The large rate of relapses during chemotherapeutic treatments of tumors is
generally explained through the paradigm Clonal Resistance (CR).1 However,
in last decade, a number of biophysical investigations [JTT99, DC01, Jai01]
revealed that a significant fraction of cases of resistance to therapy is actually
linked to phenomena that may, broadly speaking, be defined as physical resis-
tance (PR) to drugs. Perhaps the most important among these phenomena
are: a limited ability of the drug to penetrate into the tumoral tissue because
1Clonal Resistance: the emergence through fast mutations of drug-insensitive cells in
a tumor under chemotherapy.[DG09]
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of a poor or nonlinear diffusivity [AT09] and the anomalous binding of the
drug molecule to the surface of tumor cells or to extracellular matrix [GJ00].
This means that resistance cannot only be imputed to a sort of Darwinian
evolution of the cancerous population through the birth of new clones, but
also to the pharmacodynamics of the molecules of the drugs in the tumor.
Here we want to stress two possible different ways of insurgence of resistance
due to a nonlinear population interplay with noise. The presence of multiple
equilibria in the model, can make the stochastic bounded fluctuations that
affect both the carrying capacity of the tumor or the drug level in the blood,
cause the transition from a low equilibrium to a far larger value, not com-
patible with the life of the host. We propose to frame the above phenomena
as a new and non-clonal kind of resistance to chemotherapy.
7.1 Model of tumor growth in presence of
chemotherapy
Let us consider a tumor - solid or non-solid - whose size (biomass, number of
viable cells, etc..) at time t is denoted as X, and which is growing according
to a classical growth law [Whe98]:
X ′ = f
(
X
K
)
X,
where K > 0 and f(u) is a decreasing function of u for which f(1) = 0.
The value K is usually called carrying capacity, which depends on the avail-
able nutrients and/or space, for which the tumor cells compete. Another
important parameter is the value α = f(0), which we shall call ”the baseline
growth rate” (BGR), which can be read as a measure of the intrinsic growth
rate of the tumor, in absence of any competition. Of course, since f(u) is
decreasing, the BGR is also the maximal growth rate.
Two well known growth laws are the Gompertz law where f(X) = pLog(K/X),
and the generalized logistic f(X) = α(1 − (X/K)a) with a > 0. Note that
in the Gompertz case, the BGR is infinite, which is not realistic.
Let the tumor be under the delivering of a cytotoxic therapy with a drug
whose blood concentration, denoted by c(t), may be periodic or constant.
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Which is the effect of c(t) on the tumor growth? The log-kill hypothesis
[H.E86] prescribes that the rate of tumor cells killing is proportional to the
product c(t)X(t):
X ′ = f
(
X
K
)
X − γc(t)X(t). (7.1)
In the case of a bounded intrinsic growth rate, i.e. f(0) <∞, the condition
< c(t) >> f(0)/γ implies that X(t)→ 0, independently from X(0) > 0.
However, since seventies Norton and Simon [L.Na, L.Nb] stressed as a po-
tential pitfall of the log-kill hypothesis the fact that the relative killing rate
is simply taken proportional to c(t). According to the log-kill hypothesis,
the same drug concentration is indeed able to kill the same relative number
of cells per unit time independently of the tumor burden. Moreover, the
absolute velocity of regression caused by c(t) would be greater in the larger
tumors. This is often unrealistic. On the contrary, in clinics it is often ob-
served that the effort to make a large tumor regress is considerable greater,
whereas hystologically similar tumors of small volumes are curable using the
same delivered quantity of the chemotherapeutic agent. A possible cause
of this fact is the development of clones of cells that are resistant to the
delivered agent. However, since the reduced drug effectiveness may also be
present in the very first phases of a therapy, Norton and Simon [L.Na, L.Nb]
summarized this observation, by assuming that the parameter γ is not con-
stant but it is a decreasing function of X: γ(X), with γ′(X) < 0, leading to
the following non-logkill model:
X ′ = f
(
X
K
)
X − γ(X)c(t)X, X(0) = X0. (7.2)
In particular, Norton and Simon proposed that γ(X) be proportional to
f(X/K) [L.Na, L.Nb], which we shall not assume here. We thus consider
generic decreasing γ(X).
It is trivial to verify that if 〈c(t)〉 > α/γ(0) then the tumor free equilibrium
Xe = 0 is locally stable, whereas in case of constant continuous infusion,
c(t) = C, if γ(X)C > f(X/K) then the tumor free equilibrium Xe = 0 is
globally stable. In the general case, since γ(K) > f(1) = 0, if α > γ(0)C
there will be an odd number N of equilibria : X1(C,K),. . . ,XN(C,K). It is
easy matter to verify that the odd-numbered equilibria, X1(C,K),. . . XN(C,K)
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are locally stable, whereas the even numbered points X2(C,K),. . . ,XN−1(C, )
are unstable. By varying C or K one may get one ore more hysteresis bifur-
cations.
Let us suppose that γ(X)C be such that three equilibria are present. Then
standard analysis reveals that X1(C,K) and X3(C,K) will be locally stable
and X2(C,K) will be unstable, and it follows that X(t) → X1(C,K) for all
X0 ∈ (0, X2(C,K)). This means that the chemotherapy, although it does
not eliminate the neoplasm, is at least able to control the tumor size keeping
it at a low level. This result might seem a good suboptimal result in absence
of insurgence of clonal resistance.
7.2 Bounded noises introduction in the model
Apart from the clonal resistance, we shall show that the target tumor may
equally escape from the therapeutic control through stochastic fluctuation of
either the carrying capacity or the drug concentration.
As far as the carrying capacity K is, this parameter summarizes many impor-
tant phenomena related to the availability of nutrients. For example, in case
of solid tumors K depends on the growth of the neoplasia-induced vessels,
whose rate constant are unlikely constant. Moreover, the growth of tumor
depends on the general energy intake of the host organism etc..
As a consequence we shall assume that the carrying capacity is a function of
time that oscillates around an average value Km > 0:
K(t) = Km(1 + νK(t)) > 0. (7.3)
where νK(t) is a noise. We will consider both Sine Wiener and Cai noise.
As far as the chemotherapy is concerned, therapies that guarantee a constant
drug density profile as well as effectiveness do not exist in the reality, since
the drug concentration will be affected by stochastic oscillations:
c(t) = Cm(1 + νC(t)) > 0, (7.4)
where νC(t) is a noise and Cm is the average value of the drug concentration
profile.
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Thus, here we shall study the following stochastic equation:
X ′ = f
(
X
Km(1 + νK(t))
)
X − γ(X)Cm(1 + νC(t))X. (7.5)
The noisy nature of one or both the carrying capacity and the drug density in
conjunction with the inherent bistability of the tumor-therapy system, thus,
suggests that there might be the insurgence of noise-induced transitions from
the ”small” steady state X1(Cm, Km) toward the macroscopic equilibrium
state X3(Cm, K), as in other important bistable systems.
These transition would be caused by the presence of hysteresis bifurcations
that, as it is well known [J.H91], are characterized by the existence of two
values of the bifurcation parameter such that infinitesimal changes in the
value of this parameter imply that the behavior of the solution has a sudden
change. This means that near those two points the behavior of the system
is extremely sensitive to any kind of perturbations. As a result the treat-
ment requires that the fluctuations be explicitly incorporated into the model
[W.H84, W.H77].
These observations led Horsthemke and Lefever to define the theory of noise-
induced transitions (NIT) [W.H84] that investigate the phase transitions
induced by zero-mean noises in non-equilibrium systems. Such transitions
depend on the characteristics of the noise, such as its variance, and have the
effect of changing the nature of the stationary probability density function
of state variables, for example from unimodal to bimodal, or vice-versa. The
NIT theory is of the utmost interest in biomedicine, since “in-vivo the en-
vironmental situations are... extremely complex and thus likely to present
important fluctuations” [R.L79].
A classical approach consists in assuming that the stochastic perturbations
are gaussian white or colored noises. This, however, is an inappropriate so-
lution in our case for two reasons.
The first reason is that the system in study depends nonlinearly from one of
the two stochastically perturbed parameters: the carrying capacity K.
The second reason involves the fluctuations affecting C. Indeed, let us con-
sider the model (7.8) with νK(t) = 0 and let us allow that νC(t) is a gaussian
noise, implying:
dX = F (X/K)dt− γ(X)Cm(dt+ ξ(t)
√
dt),
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where ξ(t) are Gaussian random numbers.
Since the noise is unbounded, there will be a non-null probability that Cm(dt+
ξ(t)
√
dt) < 0.
In other words, there would be a non-null probability that a cytotoxic-
chemotherapy may add neoplastic cells to its target tumor, which is a non-
sense. As a consequence the gaussian noise should be avoided to investigate
the effects of fluctuations of chemotherapy. Note that also extremely large
killing rates per time units are not possible, which precludes not only gaus-
sian noises, but also lognormal noises.
For these reasons, we shall assume that both νK(t) and νC(t) are bounded
noises, i.e. that it exists a B > 0 such that |ν(t)| < B < +∞.
Since the noise-induced transitions are dependent on the kind of density of
noise adopted [Fue07], we shall assume two kind of bounded noise: The sine-
Wiener noise and The Cai noise [CS05].
To make as simple as possible our model, in our simulations we shall assume
that the tumor growth law, in absence of therapies, a generalized logistic law:
f(X/K) = α(1 − (X/K)a), where 0 < a ≤ 1. As far as γ(x) is concerned,
in absence of experimental data that may suggest some biologically plausible
γ(X), we used in our simulation a Hill-like function, which is ubiquitary in
biological modelling, and which in our case reads:
γ(X) = A
1
1 +
(
X
X∗
)n ,
where 0 < X∗ < K is a typical size tuning the action of the chemotherapy,
and n > 0 is a parameter that tunes the shape of the function (e.g. for
n >> 1 and X ≥ 0 it holds: γ(X) ≈ Heaviside(X∗ −X) ). The parameter
A embeds the baseline effectiveness of the drug dose profile c(t) for small size
tumors. Moreover, we shall non-dimensionalize the model by assuming that
Km = 1 and that α = 1, i.e. we assume that the reference size is the average
carrying capacity and that the reference time unit is the characteristic time
of growth of the tumor for small tumor size (where X ′ ≈ αX).
A major point to be stressed is that the classical theory of noise induced tran-
sitions [W.H84] is an asymptotic theory that refers to the study of the qual-
itative changes in stationary probability densities: Pst(x) = limt→∞P (x, t).
However, whatever asymptotic study might be, if the velocity of convergence
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of the stationary density is slow,it is in contradiction with the basic fact that
living beings have a finite lifespan. Thus the lifespan of the host organisms
must be a natural limit to our numerical investigations, which makes the ve-
locity of convergence to Pst(x) an essential parameter. If this velocity is slow
and the attractor is practically reached in times that are excessively greater
than the average lifespan of the organisms in study, one has to investigate the
possible qualitative changes of P (x, t) during its transitory, namely at some
given realistic times. For this reason we focused here on transitory analysis
of P (x, t). Indeed, noise has been introduced on carrying capacity and drug
concentration observing the probability density at time T = 66 correspond-
ing , in dimensional time unity, to 1 year about, both in case of Sine Wiener
and Cai noise perturbations. It must be observed that all simulations have
been done using Matlab 7.0.4.
7.3 Numerical simulations
In our simulations we considered as reference host organism for the tumor
the mouse (lifespan is 3 years about and in average tumor growth times is in
days). Namely, since the average lifespan of a mice is 3 years, since tumors
are diseases of later ages, and, finally, chemotherapies have a finite length, we
shall calculate the stationary density at one year. Since the time-dimensional
baseline growth rate of lymphoma in chimeric mice is 0.18 days−1, we shall
consider the transitory behaviors at t = 66 adimensional time units.
We considered 4 different sets of parameters and calculated the transitory
density at one year starting from the microscopic equilibrium point.
These are the sets considered:
1set: a = 1, X∗ = 0.25, n = 6, X0 = 0.105
2set: a = 1, X∗ = 0.25, n = 10, X0 = 0.100
3set: a = 2/3, X∗ = 0.262, n = 2, X0 = 0.045
4set: a = 1.1, X∗ = 0.25, n = 10, X0 = 0.123
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Bounded SW and Cai noise on carrying capacity
The first step in my numerical simulations is given by the introduction of
Sine Wiener / Cai noise on the carrying capacity: K(t). Hence we shall
study the following stochastic equation:
X ′ = f
(
X
Km(1 + νK(t))
)
X − γ(X)CmX. (7.6)
The following tables and figures show the results obtained by varying the
amplitude of the noise (B) and its correlation time (τ):
SW noise:
Amplitude (B) Correlation time (τ) 1 set* 2 set 3 set 4 set
0.01 0.1 // // // //
0.01 1 // // // //
0.01 5 // // // //
0.08 0.1 // // // //
0.08 1 // // // //
0.08 5 // // // //
0.1 0.1 // // // //
0.1 1 // // // //
0.1 5 // // // //
0.2 0.1 // // // //
0.2 1 Evasion // // //
0.2 5 Evasion // // //
0.3 0.1 // // // //
0.3 1 Evasion // Evasion //
0.3 5 Evasion // Evasion Evasion
0.4 0.1 // // // //
0.4 1 Evasion // Evasion //
0.45 0.1 Evasion // // //
0.5 0.1 Evasion // // //
0.5 1 Evasion // Evasion Evasion
0.5 5 Evasion // Evasion Evasion
0.8 1 Evasion Evasion Evasion Evasion
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Cai noise:
Amplitude (B) Correlation time (τ) 1 set 2 set 3 set 4 set
0.01 0.1 // // // //
0.01 1 // // // //
0.01 5 // // // //
0.08 0.1 // // // //
0.08 1 // // // //
0.08 5 // // // //
0.1 0.1 // // // //
0.1 1 // // // //
0.1 5 // // // //
0.2 0.1 // // // //
0.2 1 // // // //
0.2 5 // // // //
0.3 0.1 // // // //
0.3 1 // // // //
0.3 5 // // // //
0.4 0.1 // // // //
0.4 1 // // // //
0.45 0.1 // // // //
0.5 0.1 // // // //
0.5 1 Evasion // // Evasion
0.5 5 Evasion // // //
0.8 1 Evasion // Evasion Evasion
*1 set: a = 1, X∗ = 0.25, n = 6, X0 = 0.105
2 set: a = 1, X∗ = 0.25, n = 10, X0 = 0.100
3 set: a = 2/3, X∗ = 0.262, n = 2, X0 = 0.045
4 set: a = 1.1, X∗ = 0.25, n = 10, X0 = 0.123
Observations:
Introducing a SW noise, for some values of amplitude and correlation time,
I can notice a clear evasion from the point of microscopic equilibrium to the
macroscopic one (see figures). Introducing a Cai noise, as well, for some
values of amplitude and correlation time, evasion is clear.
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Perturbation on carrying capacity K
7.1.1 Sine Wiener noise 7.1.2 Cai noise
Figure 7.1: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.2 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.105.
7.2.1 Sine Wiener noise 7.2.2 Cai noise
Figure 7.2: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.2 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.1.
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7.3.1 Sine Wiener noise 7.3.2 Cai noise
Figure 7.3: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.2 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.045.
7.4.1 Sine Wiener noise 7.4.2 Cai noise
Figure 7.4: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.2 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.123.
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7.5.1 Sine Wiener noise 7.5.2 Cai noise
Figure 7.5: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.3 and correlation time τ = 5, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.105.
7.6.1 Sine Wiener noise 7.6.2 Cai noise
Figure 7.6: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.3 and correlation time τ = 5, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.1.
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7.7.1 Sine Wiener noise 7.7.2 Cai noise
Figure 7.7: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.3 and correlation time τ = 5, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.045.
7.8.1 Sine Wiener noise 7.8.2 Cai noise
Figure 7.8: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.3 and correlation time τ = 5, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.123.
141
7.9.1 Sine Wiener noise 7.9.2 Cai noise
Figure 7.9: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.4 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.105.
7.10.1 Sine Wiener noise 7.10.2 Cai noise
Figure 7.10: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.4 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.1.
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7.11.1 Sine Wiener noise 7.11.2 Cai noise
Figure 7.11: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.4 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.045.
7.12.1 Sine Wiener noise 7.12.2 Cai noise
Figure 7.12: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.4 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.123.
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7.13.1 Sine Wiener noise 7.13.2 Cai noise
Figure 7.13: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.105.
7.14.1 Sine Wiener noise 7.14.2 Cai noise
Figure 7.14: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.1.
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7.15.1 Sine Wiener noise 7.15.2 Cai noise
Figure 7.15: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.045.
7.16.1 Sine Wiener noise 7.16.2 Cai noise
Figure 7.16: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.123.
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7.17.1 Sine Wiener noise 7.17.2 Cai noise
Figure 7.17: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 5, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.105.
7.18.1 Sine Wiener noise 7.18.2 Cai noise
Figure 7.18: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 5, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.1.
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7.19.1 Sine Wiener noise 7.19.2 Cai noise
Figure 7.19: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 5, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.045.
7.20.1 Sine Wiener noise 7.20.2 Cai noise
Figure 7.20: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 5, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.123.
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7.21.1 Sine Wiener noise 7.21.2 Cai noise
Figure 7.21: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.8 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.105.
7.22.1 Sine Wiener noise 7.22.2 Cai noise
Figure 7.22: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.8 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.1.
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7.23.1 Sine Wiener noise 7.23.2 Cai noise
Figure 7.23: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.8 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.045.
7.24.1 Sine Wiener noise 7.24.2 Cai noise
Figure 7.24: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.8 and correlation time τ = 1, added on carrying capacity.
Starting value is the microscopic equilibrium point x = 0.123.
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Bounded SW and Cai noise on the drug concentration
The second step in my numerical simulations is given by the introduction of
Sine Wiener / Cai noise on drug concentration: C(t). Hence we shall study
the following stochastic equation:
X ′ = f
(
X
Km
)
X − γ(X)Cm(1 + νC(t))X. (7.7)
The following tables and figures show the results obtained by varying the
amplitude of the noise (B) and its correlation time (τ):
SW noise:
Amplitude (B) Correlation time (τ) 1 set 2 set 3 set 4 set
0.001 0.1 // // // //
0.001 1 // // // //
0.01 0.1 // // // //
0.01 1 // // // //
0.03 0.1 // // // //
0.03 1 Evasion // // //
0.04 0.1 // // // //
0.04 1 Evasion // Evasion Evasion
0.05 0.1 Evasion // // //
0.05 1 Evasion // Evasion Evasion
0.08 0.1 Evasion // Evasion Evasion
0.08 1 Evasion Evasion Evasion Evasion
0.1 1 Evasion Evasion Evasion Evasion
0.15 1 Evasion Evasion Evasion Evasion
0.2 1 Evasion Evasion Evasion Evasion
0.3 1 Evasion Evasion Evasion Evasion
0.5 1 Evasion Evasion Evasion Evasion
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Cai noise:
Amplitude (B) Correlation time (τ) 1 set 2 set 3 set 4 set
0.001 0.1 // // // //
0.001 1 // // // //
0.01 0.1 // // // //
0.01 1 // // // //
0.03 0.1 // // // //
0.03 1 // // // //
0.04 0.1 // // // //
0.04 1 // // // //
0.05 0.1 // // // //
0.05 1 // // // //
0.08 0.1 // // // //
0.08 1 // // // //
0.1 1 // // // //
0.15 1 Evasion // // //
0.2 1 Evasion // Evasion Evasion
0.3 1 Evasion Evasion Evasion Evasion
0.5 1 Evasion Evasion Evasion Evasion
Observations:
Introducing a Sine Wiener noise, for some values of amplitude and correlation
time, I can notice a clear evasion from the point of microscopic equilibrium
to the macroscopic one as it is evident in the following figures. Introducing a
Cai noise, as well, for some values of amplitude and correlation time, evasion
is clear.
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Perturbation on drug concentration C
7.25.1 Sine Wiener noise 7.25.2 Cai noise
Figure 7.25: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.05 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.105.
7.26.1 Sine Wiener noise 7.26.2 Cai noise
Figure 7.26: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.05 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.1.
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7.27.1 Sine Wiener noise 7.27.2 Cai noise
Figure 7.27: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.05 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.045.
7.28.1 Sine Wiener noise 7.28.2 Cai noise
Figure 7.28: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.05 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.123.
153
7.29.1 Sine Wiener noise 7.29.2 Cai noise
Figure 7.29: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.08 and correlation time τ = 0, 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.105.
7.30.1 Sine Wiener noise 7.30.2 Cai noise
Figure 7.30: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.08 and correlation time τ = 0, 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.1.
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7.31.1 Sine Wiener noise 7.31.2 Cai noise
Figure 7.31: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.08 and correlation time τ = 0, 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.045.
7.32.1 Sine Wiener noise 7.32.2 Cai noise
Figure 7.32: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with am-
plitude B = 0.08 and correlation time τ = 0, 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.123.
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7.33.1 Sine Wiener noise 7.33.2 Cai noise
Figure 7.33: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.15 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.105.
7.34.1 Sine Wiener noise 7.34.2 Cai noise
Figure 7.34: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.15 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.1.
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7.35.1 Sine Wiener noise 7.35.2 Cai noise
Figure 7.35: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.15 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.045.
7.36.1 Sine Wiener noise 7.36.2 Cai noise
Figure 7.36: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.15 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.123.
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7.37.1 Sine Wiener noise 7.37.2 Cai noise
Figure 7.37: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.2 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.105.
7.38.1 Sine Wiener noise 7.38.2 Cai noise
Figure 7.38: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.2 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.1.
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7.39.1 Sine Wiener noise 7.39.2 Cai noise
Figure 7.39: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.2 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.045.
7.40.1 Sine Wiener noise 7.40.2 Cai noise
Figure 7.40: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.2 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.123.
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7.41.1 Sine Wiener noise 7.41.2 Cai noise
Figure 7.41: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.3 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.105.
7.42.1 Sine Wiener noise 7.42.2 Cai noise
Figure 7.42: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.3 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.1.
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7.43.1 Sine Wiener noise 7.43.2 Cai noise
Figure 7.43: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.3 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.045.
7.44.1 Sine Wiener noise 7.44.2 Cai noise
Figure 7.44: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.3 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.123.
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7.45.1 Sine Wiener noise 7.45.2 Cai noise
Figure 7.45: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.105.
7.46.1 Sine Wiener noise 7.46.2 Cai noise
Figure 7.46: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.1.
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7.47.1 Sine Wiener noise 7.47.2 Cai noise
Figure 7.47: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.045.
7.48.1 Sine Wiener noise 7.48.2 Cai noise
Figure 7.48: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure),with
amplitude B = 0.5 and correlation time τ = 1, added on drug concentration.
Starting value is the microscopic equilibrium point x = 0.123.
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Bounded SW and Cai noise in both carrying capacity and drug
density
The last step in my numerical simulations is given by the introduction of Sine
Wiener / Cai noise on both carrying capacity K(t) and drug concentration
C(t). Hence we shall study the following stochastic equation:
X ′ = f
(
X
Km(1 + νK(t))
)
X − γ(X)Cm(1 + νC(t))X. (7.8)
The following tables and figures show the results obtained by varying the
amplitude of the noise (B) and its correlation time (τ):
SW noise:
Bc Bk τc τk 1 set 2 set 3 set 4 set
0.01 0.01 0.1 0.1 // // // //
0.01 0.01 1 1 // // // //
0.01 0.01 1 5 // // // //
0.02 0.02 1 1 // // // //
0.02 0.02 1 1 // // // //
0.02 0.02 1 5 // // // //
0.03 0.03 0.1 0.1 // // // //
0.03 0.03 1 1 Evasion // Evasion //
0.05 0.05 0.1 0.1 Evasion // // //
0.05 0.05 1 1 Evasion // Evasion Evasion
0.05 0.05 1 5 Evasion // Evasion Evasion
0.1 0.04 1 0.1 Evasion Evasion Evasion Evasion
0.2 0.04 1 0.1 Evasion Evasion Evasion Evasion
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Cai noise:
Bc Bk τc τk 1 set 2 set 3 set 4 set
0.01 0.01 0.1 0.1 // // // //
0.01 0.01 1 1 // // // //
0.01 0.01 1 5 // // // //
0.02 0.02 1 1 // // // //
0.02 0.02 1 1 // // // //
0.02 0.02 1 5 // // // //
0.03 0.03 0.1 0.1 // // // //
0.03 0.03 1 1 // // // //
0.05 0.05 0.1 0.1 // // // //
0.05 0.05 1 1 // // // //
0.05 0.05 1 5 // // // //
0.1 0.04 1 0.1 // // // //
0.2 0.04 1 0.1 Evasion // Evasion Evasion
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Perturbation on carrying capacity K and drug concentration C
7.49.1 Sine Wiener noise 7.49.2 Cai noise
Figure 7.49: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.02 and correlation time τk = 5, and
drug concentration, with amplitude Bc = 0.02 and correlation time τc = 1,.
Starting value is the microscopic equilibrium point x = 0.105.
7.50.1 Sine Wiener noise 7.50.2 Cai noise
Figure 7.50: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.02 and correlation time τk = 5, and
drug concentration, with amplitude Bc = 0.02 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.1.
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7.51.1 Sine Wiener noise 7.51.2 Cai noise
Figure 7.51: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.02 and correlation time τk = 5, and
drug concentration, with amplitude Bc = 0.02 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.045.
7.52.1 Sine Wiener noise 7.52.2 Cai noise
Figure 7.52: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.02 and correlation time τk = 5, and
drug concentration, with amplitude Bc = 0.02 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.123.
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7.53.1 Sine Wiener noise 7.53.2 Cai noise
Figure 7.53: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 0.1,
and drug concentration, with amplitude Bc = 0.05 and correlation time
τc = 0.1,. Starting value is the microscopic equilibrium point x = 0.105.
7.54.1 Sine Wiener noise 7.54.2 Cai noise
Figure 7.54: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 0.1,
and drug concentration, with amplitude Bc = 0.05 and correlation time
τc = 0, 1. Starting value is the microscopic equilibrium point x = 0.1.
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7.55.1 Sine Wiener noise 7.55.2 Cai noise
Figure 7.55: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 0.1,
and drug concentration, with amplitude Bc = 0.05 and correlation time
τc = 0.1. Starting value is the microscopic equilibrium point x = 0.045.
7.56.1 Sine Wiener noise 7.56.2 Cai noise
Figure 7.56: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 0.1,
and drug concentration, with amplitude Bc = 0.05 and correlation time
τc = 0.1. Starting value is the microscopic equilibrium point x = 0.123.
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7.57.1 Sine Wiener noise 7.57.2 Cai noise
Figure 7.57: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 1, and
drug concentration, with amplitude Bc = 0.05 and correlation time τc = 1,.
Starting value is the microscopic equilibrium point x = 0.105.
7.58.1 Sine Wiener noise 7.58.2 Cai noise
Figure 7.58: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 1, and
drug concentration, with amplitude Bc = 0.05 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.1.
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7.59.1 Sine Wiener noise 7.59.2 Cai noise
Figure 7.59: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 1, and
drug concentration, with amplitude Bc = 0.05 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.045.
7.60.1 Sine Wiener noise 7.60.2 Cai noise
Figure 7.60: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 1, and
drug concentration, with amplitude Bc = 0.05 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.123.
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7.61.1 Sine Wiener noise 7.61.2 Cai noise
Figure 7.61: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 5, and
drug concentration, with amplitude Bc = 0.05 and correlation time τc = 1,.
Starting value is the microscopic equilibrium point x = 0.105.
7.62.1 Sine Wiener noise 7.62.2 Cai noise
Figure 7.62: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 5, and
drug concentration, with amplitude Bc = 0.05 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.1.
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7.63.1 Sine Wiener noise 7.63.2 Cai noise
Figure 7.63: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 5, and
drug concentration, with amplitude Bc = 0.05 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.045.
7.64.1 Sine Wiener noise 7.64.2 Cai noise
Figure 7.64: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.05 and correlation time τk = 5, and
drug concentration, with amplitude Bc = 0.05 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.123.
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7.65.1 Sine Wiener noise 7.65.2 Cai noise
Figure 7.65: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.04 and correlation time τk = 0.1,
and drug concentration, with amplitude Bc = 0.1 and correlation time τc =
1,. Starting value is the microscopic equilibrium point x = 0.105.
7.66.1 Sine Wiener noise 7.66.2 Cai noise
Figure 7.66: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.04 and correlation time τk = 0, 1,
and drug concentration, with amplitude Bc = 0.1 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.1.
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7.67.1 Sine Wiener noise 7.67.2 Cai noise
Figure 7.67: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.04 and correlation time τk = 0, 1,
and drug concentration, with amplitude Bc = 0.1 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.045.
7.68.1 Sine Wiener noise 7.68.2 Cai noise
Figure 7.68: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.04 and correlation time τk = 0, 1,
and drug concentration, with amplitude Bc = 0.1 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.123.
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7.69.1 Sine Wiener noise 7.69.2 Cai noise
Figure 7.69: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.04 and correlation time τk = 0.1,
and drug concentration, with amplitude Bc = 0.2 and correlation time τc =
1,. Starting value is the microscopic equilibrium point x = 0.105.
7.70.1 Sine Wiener noise 7.70.2 Cai noise
Figure 7.70: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.04 and correlation time τk = 0, 1,
and drug concentration, with amplitude Bc = 0.2 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.1.
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7.71.1 Sine Wiener noise 7.71.2 Cai noise
Figure 7.71: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.04 and correlation time τk = 0, 1,
and drug concentration, with amplitude Bc = 0.2 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.045.
7.72.1 Sine Wiener noise 7.72.2 Cai noise
Figure 7.72: Xfinal probability density over 1000 simulations with bounded
Sine Wiener noise (left figure) and bounded Cai noise (right figure)added on
carrying capacity, with amplitude Bk = 0.04 and correlation time τk = 0, 1,
and drug concentration, with amplitude Bc = 0.2 and correlation time τc = 1.
Starting value is the microscopic equilibrium point x = 0.123.
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7.4 Conclusions
As we can see from the results, the statistical fluctuations does not make the
tumor evade in all cases.
In the case of perturbations on the carrying capacity we may summarize as
follows the results of our simulations for the various parametric sets:
• 1 set: In the case of SW noise, starting from equilibrium point X0 =
0.105 for B = 0.2, τ = 1, 5; B = 0.3, τ = 1, 5; B = 0.4, τ = 1;
B = 0.45, τ = 0, 1; B = 0.5, τ = 0.1, 1, 5; B = 0.8, τ = 1 there is transi-
tion to bimodality with a considerable probability of tumor explosion.
In the case of Cai noise we observe transition only for B = 0.5, τ = 1, 5;
B = 0.8, τ = 1.
• 2 set: In the case of SW noise, starting from equilibrium point X0 =
0.100 for B = 0.8, τ = 1 there is transition to bimodality with a con-
siderable probability of tumor explosion. In the case of Cai noise we
do not observe transition in any case.
• 3 set: In the case of SW noise, starting from equilibrium point X0 =
0.045 for B = 0.3, τ = 1, 5; B = 0.4, τ = 1; B = 0.5, τ = 1, 5;
B = 0.8, τ = 1 there is transition to bimodality with a considerable
probability of tumor explosion. In the case of Cai noise we observe
transition only for B = 0.8, τ = 1.
• 4 set: In the case of SW noise, starting from equilibrium point X0 =
0.123 for B = 0.3, τ = 5; B = 0.5, τ = 1, 5; B = 0.8, τ = 1 there is tran-
sition to bimodality with a considerable probability of tumor explosion.
In the case of Cai noise we observe transition only for B = 0.5, τ = 1;
B = 0.8, τ = 1.
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Similarly, in the case of perturbations on the drug concentration we have
that:
• 1 set: In the case of SW noise, starting from equilibrium point X0 =
0.105 for B = 0.03, τ = 1; B = 0.04, τ = 1; B = 0.05, τ = 0.1, 1;
B = 0, 08, τ = 0.1, 1; B = 0.1, τ = 1; B = 0.15, τ = 1; B = 0.2, τ = 1;
B = 0.3, τ = 1; B = 0.5, τ = 1, there is transition to bimodality
with a considerable probability of tumor explosion. In the case of Cai
noise we observe transition only for B = 0.15, τ = 1; B = 0.2, τ = 1;
B = 0.3, τ = 1; B = 0.5, τ = 1.
• 2 set: In the case of SW noise, starting from equilibrium point X0 =
0.100 for B = 0, 08, τ = 0.1, 1; B = 0.1, τ = 1; B = 0.15, τ = 1;
B = 0.2, τ = 1; B = 0.3, τ = 1; B = 0.5, τ = 1, there is transition
to bimodality with a considerable probability of tumor explosion. In
the case of Cai noise we observe transition only for B = 0.3, τ = 1;
B = 0.5, τ = 1.
• 3 set: In the case of SW noise, starting from equilibrium point X0 =
0.045 for B = 0.04, τ = 1; B = 0.05, τ = 1; B = 0, 08, τ = 0.1, 1;
B = 0.1, τ = 1; B = 0.15, τ = 1; B = 0.2, τ = 1; B = 0.3, τ = 1;
B = 0.5, τ = 1, there is transition to bimodality with a considerable
probability of tumor explosion. In the case of Cai noise we observe
transition only for B = 0.2, τ = 1; B = 0.3, τ = 1; B = 0.5, τ = 1.
• 4 set: In the case of SW noise, starting from equilibrium point X0 =
0.045 for B = 0.04, τ = 1; B = 0.05, τ = 1; B = 0, 08, τ = 0.1, 1;
B = 0.1, τ = 1; B = 0.15, τ = 1; B = 0.2, τ = 1; B = 0.3, τ = 1;
B = 0.5, τ = 1, there is transition to bimodality with a considerable
probability of tumor explosion. In the case of Cai noise we observe
transition only for B = 0.2, τ = 1; B = 0.3, τ = 1; B = 0.5, τ = 1.
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Clearly, transitions depend on the noise model adopted and also on the
initial point considered. This observation also holds by considering stochastic
perturbations on both carrying capacity and drug density.
From a biological point of view, we may say that:
• The stochastic fluctuations that unavoidably arise in the tumor micro-
environment, which are modeled by means of bounded noises perturb-
ing the tumoral carrying capacity, may cause the escape of the tumor
from the control imposed by the chemotherapy;
• Stochastic oscillations in chemotherapy level joined with nonlinear tu-
mor size-dependent effectiveness of the delivered agent may induce tu-
mor relapse;
• Synergistic effects are possible;
Note that none of the above mechanisms is related to emergence of resistent
clones in the tumor cells population.
In conclusion, our results seem to show that stochastic perturbations may
contribute to triggering the tumor escape, although less easily than one
might predict by assuming a Gaussian noise. Also here, as in our immuno-
oncological simulations, one can observe that, limiting the analysis at finite
significant time (T=66), the transition to larger values is not reached if the
oscillation B of the noise is too small or if the autocorrelation time τ is small.
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